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Cyclic diguanylate (c-di-GMP) signalling affects developmental transitions of diverse 
bacteria. While much is known about c-di-GMP signalling, the question remains on 
how signalling enzymes that contain both domains that synthesize and degrade c-di-
GMP, respectively, regulate c-di-GMP levels. Additionally, how do these subtle 
changes in c-di-GMP concentrations affect cellular phenotypes? In this study, we 
address these two broad research questions using the bidomain sensor-regulator MorA 
of Pseudomonas spp. 
Previously, we reported that MorA controls motility by affecting the number and 
timing of flagellar development, and, biofilm formation in Pseudomonas putida. Here, 
we characterized the flagellar motor function of Pseudomonas aeruginosa and 
describe the effect of MorA. Unlike the enteric bacteria model, the Pseudomonas 
flagellar motor rotates in the clockwise direction for significant periods, and the 
flagellar rotations are interspersed with pauses. MorA controls forward swimming 
speeds and pauses of the flagellar motor function. These phenotypes, are, in turn, 
controlled via the function of MorA catalytic domains. 
We addressed the catalytic function of these domains and show that MorA has a 
dominant diguanylate cyclase (DGC) activity. The phosphodiesterase (PDE) domain 
seems to have significantly lost its activity, but it has acquired two additional 
regulatory properties. The PDE domain significantly affects DGC activity via two 
novel inter-domain interactions. Firstly, the PDE domain constitutively imparts a 6-
fold increase in DGC activity through glutamate of its EAL motif. Secondly, the PDE 
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domain reduces DGC activity through product inhibition in a dose-dependent manner 
via leucine of its EAL motif. A mutation in either residue abolishes the low level of 
PDE activity. Hence, this is the first report on how allosteric regulation of DGC 
activity by the weakly active PDE domain leads to finely-tuned c-di-GMP levels. 
The enzymatic activities corroborate with in vivo findings on motility and biofilm 
formation. Both the loss of morA and ΔmorA expressing a MorA DGC point mutant 
both lead to similar biological outcomes - reduced intracellular c-di-GMP levels, 
increased motility and loss of biofilm initiation. Hence, MorA controls these cellular 
functions through its dominant DGC activity. Effects of the PDE domain on DGC 
activity also altered the two biological functions. The constitutive positive regulation 
affected motility, biofilm initiation, and biofilm formation at a later stage of biofilm 
development. Interestingly, product inhibition affected only biofilm initiation. During 
the later stage of biofilm development, PDE activation occurred, as shown by 
increased biofilm formation by PDE mutants. This is the first report of a stage–
dependent activation of a signalling enzyme domain. While sensors have been 
previously identified, these effects were not. Taken together, these findings highlight 
the biological significance of inter-domain interactions in MorA, where the regulation 
of c-di-GMP levels act to control motility and biofilm development in a pathway- and 
stage-specific manner.  
The PAS sensory domain of MorA controlled the motility and biofilm formation 
upstream of c-di-GMP signalling. A mutation in the PAS domain affected the DGC 
activity of MorA most noticeably. The PAS sensory domain, therefore, affect c-di-
GMP levels by regulating DGC function in vivo. 
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Typically, multiple cellular pathways have been shown to be coordinated through 
effector proteins. Here, we show that the control begins at the level of enzyme action, 
through the regulation of c-di-GMP production. Both sensory and catalytic domains 
play a crucial role in this process. The evolution of the signalling PDE domain from 
an enzymatic to a regulatory function has enabled a fine-tuned control of DGC 
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Chapter 1. Introduction 





Bacteria generally exist in two states in their lifecycle, as individual cells in the 
planktonic state, or in communities as surface-attached biofilms. In the planktonic 
state, bacterial cells swim freely and undergo a typical sigmoidal growth pattern. They 
first adapt to their environment and mature to grow, following which, they enter an 
exponential growth phase, where they rapidly divide. If nutrients are further depleted, 
bacteria may then enter a stationary phase, during which the flagellar apparatus also 
fully develops. Biofilms, on the other hand, are formed when free-swimming bacteria 
come in contact with surfaces and the cells attach to the surface. During this process, 
flagella are shed and cells become non-motile. As cells multiply, a community is 
formed as the biofilm develops into a macroscopic structure. It goes through a multi-
stage developmental process that involves initiation, irreversible attachment, 
development of the biofilm structure, maturation, and finally biofilm dispersal.   
In free-swimming planktonic cells, motility is vital for survival as it allows the cell to 
move away from unfavourable environments and toward areas where it is beneficial 
for development. Bacterial cells can utilize different types of mechanisms to move, 
such as pili-based twitching motility, slime-based gliding motility, and flagellum-
based swimming motility, among others. Flagellum-based motility contributes most 
significantly to the movements of flagellated cells, and is well-characterized in the 
Escherichia coli model, where flagellar structure and assembly, flagellar motor 
function, flagellar switch, and their controls have been described thoroughly in 
literature. However, the presentation of flagella in peritrichous E. coli is very different 
from other bacterial strains, such as those of monotrichous Pseudomonas aeruginosa 
and multitrichous Pseudomonas putida. Controls of motility and flagellar structure 
 3 
 
may also have different outcomes in these cells.  How then, do these other cells move, 
and how do the control mechanism affect the flagellar function? 
Cells also attach to surfaces and form communities of biofilms where their physiology, 
gene expression profiles, and characteristics are vastly different from those of 
planktonic cells. Cells, after attaching to a surface shed flagella and become non-
motile. They also secrete extracellular polysaccharides to allow adhesion to the 
surfaces and aggregate to form monolayers that eventually develop into a macroscopic 
structure. As the biofilm often behaves like an organ, cells in the biofilm community 
also differentiate to perform different roles. The control and development of biofilm 
formation across its many stages is therefore a complex process involving multiple 
signal processes. Control of many of these stage-dependent processes is currently less 
known. Therefore, the study of these processes and their control mechanism is of 
scientific and medical interest. Pseudomonas spp. is a model organism for many 
studies on biofilm. 
External or intrinsic signals can trigger changes from one type of developmental stage 
to another. These signals are perceived via sensors, which are then transferred via such 
signalling systems to different pathways.  As expected, both complex phenomena of 
motility and biofilm formation are under complicated control systems. Recently, such 
a mode of control for both motility and biofilm has been reported, which is that of 
cyclic diguanylate (c-di-GMP) signalling. Cyclic diguanylate signalling proteins are 
known to detect external signals and, in turn, regulate c-di-GMP levels, which then 
result in different phenotypic outcomes. The signalling enzymes, diguanylate cyclase 
(DGC) and phosphodiesterase (PDE) control c-di-GMP levels in the cells, by 
synthesizing and degrading c-di-GMP, respectively. As a result of these enzyme 
 4 
 
activities, changes in levels of c-di-GMP can thus affect different biological processes 
such as motility and biofilm formation through either transcriptional or post-
transcriptional control. 
We have previously described a membrane-localized global sensor regulator MorA 
that is conserved across Pseudomonas spp. (Choy et al., 2004). MorA contains 
sensory PAS/PAC domains in combination with c-di-GMP signalling GGDEF and 
EAL domains. MorA controls the timing of flagellar development, motility, 
chemotaxis, and biofilm formation in P. putida. In this Thesis, we investigate the 
catalytic property of MorA, and also its role in regulating motility and biofilm 
formation in two different species of the same genus. Therefore, we set the following 
objectives for this study: 
1) To describe swimming motility between monotrichous and multitrichous 
Pseudomonas spp., and the role of MorA in P. aeruginosa motility (Chapter 
4).  
We propose to study the swimming motility characteristics of these two 
Pseudomonas species which possess single and multiple flagellar apparatus 
that are both polar localized. We optimized conditions to study P. aeruginosa 
motility and motor function. 
2) To elucidate the activity of the catalytic domains of MorA (Chapter 5). As 
MorA contains both the GGDEF and EAL domains, and is potentially 
bifunctional, we propose to elucidate the catalytic activity of MorA through in 
vitro assays of the catalytic bidomains. We will establish the role of respective 
domains by using site-directed mutant proteins. 
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3) To investigate the mechanisms of inter-domain interactions of MorA 
(Chapter 5). Based on enzymatic studies using proteins with mutations in 
DGC or PDE catalytic motifs, we identified inter-domain effects.  These 
effects were studied in detail in this Chapter. 
4) To investigate the biological outcomes of inter-domain interactions of MorA 
(Chapter 6). Findings based on in vitro studies were corroborated with their 
biological functions on motility and biofilm formation by expressing full-
length proteins in ΔmorA strains. 
This Thesis is organized into Chapters on a general Introduction, Literature review, 
Materials and methods, and three independent Results Chapters, which also 
incorporates discussion. A Chapter on Conclusions summarizes the overall 
findings of the Thesis. We also propose a model on how MorA regulates 








Chapter 2. Literature review 




2. Literature review 
2.1. Cyclic diguanylate (c-di-GMP) signalling in bacteria 
Signal transduction networks exist in bacteria to sense environmental and intrinsic 
cues so as to effect different cellular responses. These signalling systems include those 
of cell-cell signalling (quorum sensing), two-component phosphorelays, as well as 
second messenger signalling (Camilli, 2006). Second-messenger signalling paradigms 
in bacteria were first described for cAMP (Kolb et al.,1993), and the alarmone ppGpp 
(Reviewed in: Potrykus and Cashel, 2008). The more complex and ubitiquous second 
messenger, c-di-GMP (bis-(3’-5’)-cyclic dimeric guanosine monophosphate), was 
only identified much later, where it was first discovered as an allosteric activator of 
cellulose synthase in Gluconacetobacter xylinus (Ross et al., 1987). To date, levels of 
c-di-GMP is known to regulate a range of key bacterial functions including motility, 
biofilm formation, developmental transitions and pathogenesis, to name a few 
(Romling and Amikam, 2006). 
The turnover of c-di-GMP is controlled by the opposing action of the enzymes 
diguanylate cyclase (DGC), which catalyzes its synthesis, and phosphodiesterase 
(PDE), which catalyzes its hydrolysis (Tal et al., 1998). DGCs, encoded by the 
GGDEF domain, synthesize c-di-GMP from GTP, whereas PDEs, encoded by EAL or 
HD-GYP domains, hydrolyzes c-di-GMP into pGpG or GMP, respectively. 
Proteins with these domains can be found widely in most bacterial phyla but are 
absent from archaea and eukarya (Jenal, 2004). A significant number of these proteins 
show a multimodular arrangement, in which the DGC and/or PDE domains are fused 
to various signal receiver and/or localization domains, suggesting that they use c-di-
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GMP as a second messenger to link the sensing of specific environmental cues to 
appropriate alterations in bacterial physiology and behaviour.   
The signals sent by c-di-GMP are then transferred to different output functions 
through the binding of c-di-GMP to effector components. Currently, four types of c-
di-GMP effector classes/families are known. The PilZ family proteins, FleQ 
transcription factor, PelD, and I-site effectors (Hengge, 2009). Riboswitches that carry 
the conserved RNA GEMM (genes for the environment, membranes and motility) 
domain also bind to c-di-GMP as a ligand (Sudarsan et al., 2008). The binding of c-di-
GMP to these effectors, in turn, regulate different cellular functions (Fig. 2-1). 
Using such c-di-GMP signalling modules (Fig. 2-1), a large variety of extrinsic and 
cellular cues have been incorporated to regulate different cellular phenotypes (Fig. 2-
2). For example, low-oxygen concentrations are sensed by the PAS domain in RbdA 
which then controls its PDE activity in regulation of biofilm dispersal (An et al., 
2010). Incorporation of signals from other systems, such as quorum sensing signals 
(Waters et al., 2008), have also been shown to regulate c-di-GMP levels. For the case 
of the DGC, TpbB, quorum sensing signals activate phosphatase action on TpbB, 
which becomes deactivated, and reduces biofilm formation (Ueda and Wood, 2009). 
Other examples of signal integration through c-di-GMP signalling include the 
incorporation of diffusible signal factor to the control of biofilm dispersal and 
virulence (Lim et al., 2006), environmental signals to twitching motility (Huang et al., 
2003), as well as the histone-like nucleoid structuring protein (H-NS) to curli 






Fig. 2-1. Components of a c-di-GMP signalling module. Different environmental 
cues are detected by sensory domains which, in turn, trigger the activity of DGCs or 
PDEs found on the same protein. Levels of c-di-GMP are then modulated. Effector 
proteins bind to c-di-GMP and subsequently control functions such as motility and 
biofilm formation. Note that the modular architecture of c-di-GMP signalling enzymes 
allows great diversity in their domain combinations. [Figure adapted from: Karatan 







 Fig. 2-2. Input and output signals of c-di-GMP metabolism.  GGDEF and 
EAL/HD-GYP domains control the synthesis and degradation of c-di-GMP. Different 
environmental cues (left) are sensed by signalling enzymes that act to alter c-di-GMP 
levels. Levels of c-di-GMP then act to regulate different cellular processes (right). 
[Figure adapted from: Römling et al., 2005] 
 
2.1.1. Occurrence of c-di-GMP signalling enzymes  
Current databases report nearly 11,248 GGDEF and EAL domain-containing proteins, 
where, 9943 proteins possess the GGDEF domain and, 5574 the EAL domain 
(Seshasayee et al., 2010). Of these GGDEF and EAL domain proteins, a subset of 
3769 hybrid GGDEF-EAL bidomain proteins are present (Fig. 2-3). These proteins 
were found widely across 867 prokaryotic genomes and the number of c-di-GMP 
signalling proteins within each species also varies. In general, many such proteins are 
found in Gammaproteobacteria genomes (~22), but Firmicutes and Actinobacteria 
usually have only a few per genome. For P. aeruginosa, a model species used in our 
study, about 17 proteins encode a DGC domain, 5 with a PDE domain, and 16 contain 








































Fig. 2-3. Occurrence of GGDEF and EAL-containing domains across 867 
bacterial genomes. GGDEF-EAL, GGDEF-only and EAL-only domain containing 
proteins are reflected in green, yellow and blue boxes respectively. “+” indicates an 
intact active site while “-” indicates a degenerate site. The number of GGDEF proteins 
with an intact c-di-GMP-binding allosteric inhibitory site (I-site) is indicated in 
brackets. [Figure adapted from: Seshasayee et al., 2010] 
The presence of such large numbers of c-di-GMP signalling enzymes within a single 
species suggests redundancy. However, this is only observed in some cases where, 
different proteins seem to adjust general intracellular c-di-GMP levels, which in turn 
regulate phenotypes through specific regulators (Boehm et al., 2010). In most cases, 
however, specific signalling enzymes contribute and alter specific cellular functions 
(Kuchma et al., 2007; Huang et al., 2003). Therefore, the question arises on how the 
activities of these individual proteins are separated in order to minimize cross-talk 
among distinct signal outputs? 
The sequestration of c-di-GMP signalling enzymes was suggested to explain how 
signalling specificity exist among these large sets of signalling enzymes (Hengge 
2009). It has been shown that expression levels of c-di-GMP signalling genes can vary 
under different conditions (Weber et al., 2006; Jonas et al., 2008), thus allowing 
different sets of enzymes to be active at each point in time. In addition, temporal 
sequestration also exist when proteolysis of specific c-di-GMP signalling enzymes 
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take place (Perry et al., 2004). A third mode of sequestration is that of functional 
sequestration, where signalling occurs through certain effectors that are associated by 
specific protein-protein interactions (Ryan et al., 2006). Additionally, the distinct 
localization of these signalling enzymes may also affect how they function (Paul et al., 
2004; Ryan et al., 2006). The sequestration of c-di-GMP signalling enzymes through 
these different ways are typically mediated by partner domains found on the same 
protein. These partner domains may sense specific environmental cues or have 
localization signals (Table 1-1), hence, accounting for the diverse domain 
architectures that c-di-GMP signalling enzymes have. 
Table 1-1. Spatial localization signals and partner domain occurrence for 
GGDEF and EAL proteins 
 GGDEF EAL Hybrid 
Total proteins 5674  1805 3769 
Localization signals    
With localization signal1 n (%) 3193 (56) 643 (36)  2142 (56)
Sec signal peptide, n 3090  605  2030 
Tat signal peptide, n 1438 417  1076 
Lipoprotein signal, n 112  14  100 
Partner domains    
With partner domains 2550 (45)  473 (26)  2636 (70) 
With PAS domain  801  21  1740 
With GAF domain  445  41  357 
With REC domain  552  123  237 
With HAMP domain  327  6  394 
With HDOD domain  28  128  0 
With unannotated sequence2 1195  491  507 
1The sets of proteins corresponding to each of the four localization signals are not 
mutually exclusive. 96% of proteins containing at least one of the four signals have 
transmembrane helices. 
2Proteins with unannotated sequence stretches (>100 amino acids) are not included 
in the total number of proteins with partner domains. 





2.1.2. Regulation of c-di-GMP levels by DGCs 
While regulation of c-di-GMP may take place through the sequestration of c-di-GMP 
signalling enzymes, the signalling enzymes also possess intrinsic regulatory 
mechanisms. These mechanisms alter enzyme activities which produce or degrade c-
di-GMP, which therefore regulate overall c-di-GMP levels.  
In DGCs, dimerization is a prerequisite for activity, as GTP binds singly to the active 
site (A-site) of each DGC monomer. For synthesis of c-di-GMP, two molecules of 
GTP have to come in close proximity for cyclization, and dimerization would 
facilitate this. The A-site of DGCs is thus located at the interface between each 
monomer, and it corresponds to the GGDEF motif. All residues, except for aspartic 
acid, were found to be crucial for enzymatic activity (Kirillina et al., 2004). The 
ability to form stable dimers has been shown to activate and increase DGC activity 
(Paul et al., 2007; De et al., 2008).  
A mode of regulation also exists in DGCs to prevent such dimerization, and, in turn, 
DGC activity. This takes place through allosteric product inhibition, where c-di-GMP 
binding to an inhibitory site (I-site) causes the formation of elongated dimers that 
therefore prevents the formation of the A-site (Chan et al., 2004). Such product 
inhibition thus creates a system of feedback control that prevents excessive GTP 
utilization and over-accumulation of c-di-GMP (Fig. 2-4). Notably, for GGDEF 
domain proteins with intact A-sites, about 48% contain the I-site in hybrid proteins, 
while about 67% of GGDEF-only proteins possess it (Seshasayee et al., 2010). The 
wide occurrence of the I-site across GGDEF-proteins suggests that a distinct number 










Fig. 2-4. Allosteric product inhibition of DGC.  The process of c-di-GMP 
formation begins when GTP binds to a DGC monomer at the A-site (top left). 
Dimerization takes place, allowing GTP molecules to come together and form c-di-
GMP (top right). In the case of product inhibition, excess c-di-GMP binds to the I-
site of DGCs (bottom). This results in the formation of elongated dimers which 
prevents further formation of c-di-GMP [Figure adapted from: Chan et al., 2004].  
 
2.1.3. Regulation of c-di-GMP levels by PDEs 
PDEs, which are encoded by EAL domains, on the other hand, function as monomeric 
enzymes that hydrolyze c-di-GMP phosphodiester bond to form pGpG. Non-specific 
cellular PDEs then further break pGpG down to GMP. This catalysis is known to be 
Mg2+ or Mn2+-dependent, and is inhibited by Ca2+ and Zn2+ ions (Rao et al., 2008). A 
second type of c-di-GMP-specific PDE is encoded by HD-GYP domain proteins, 
which form a subfamily of the HD superfamily of metal-dependent 
phosphohydrolases (Ryan et al., 2006). Such PDEs can hydrolyze c-di-GMP to pGpG 
and breakdown pGpG to GMP. To date, regulatory mechanisms within the PDE 
domains have not been found. Activation of PDE activity, however, has been reported 
in hybrid GGDEF-EAL proteins where GTP binds to a degenerate GGDEF domain 




2.1.4. GGDEF-EAL bidomain proteins 
As mentioned earlier in Chapter 2.1.1, 3769 out of 11248 GGDEF and EAL domain-
containing proteins are GGDEF-EAL bidomain proteins. It is intriguing why c-di-
GMP bidomain signalling enzymes, with potentially opposing enzymatic activities, 
are widely encoded by microbial genomes?  Functioning of the bidomain proteins 
seem to fall in three general categories. In many cases, only one of the GGDEF-EAL 
domains is active, while the other domain is inactive due to degenerate sequences that 
might have been functional at an earlier stage in their evolution. Examples include 
GcpC and GcpF, which are bidomain proteins involved in cellulose synthesis. In vivo 
assays showed that they are functionally DGCs and not PDEs (García et al., 2004).  
YciR, which regulates the transcription of CgsD, a curli and cellulose regulator, on the 
other hand, is an example of a bidomain protein with PDE but not DGC activity 
(Weber et al., 2006). 
Another class is represented by BphG1 and SrcC, where both domains are functional, 
but triggers such as light or the presence of other proteins activate one or the other 
enzyme activity. For BphG1, the protein cleaves into two species when expressed in E. 
coli, where the larger species exhibited DGC activity, and the smaller species had 
light-activated PDE activity (Tarutina et al., 2006). In the case of ScrC, the protein 
was found to regulate the switch between a highly motile and biofilm-forming 
bacterium, where in vivo, ScrC acts as a PDE when co-expressed with ScrA and ScrB 
(Ferreira et al., 2008). However, when expressed alone, cellular c-di-GMP levels 
increase, suggesting that it also acts as a DGC. 
The last category consists of cases involved inter-domain interactions, where one 
common example involves nucleotide (GTP) binding to the DGC domain, which then 
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activates PDE activity. FimX, CC3396, and RbdA, are examples of such proteins, 
where in FimX and RbdA, the GGDEF domain has also been shown to be required for 
their roles in twitching motility and biofilm dispersal, respectively (Christen et al., 
2005; Kazmierczak et al., 2006; An et al., 2010). In the bifunctional MtbDGC, a 
cysteine mutation in the PDE domain removed both DGC and PDE activities, 
suggesting that inter-domain interactions are also present (Gupta et al., 2010). 
2.2. Mechanisms of control for output pathways: swimming motility 
In the life cycle of bacteria, there are generally two lifestyles, where bacteria exist as 
free-swimming planktonic cells, or as a community of cells in a biofilm. It is 
important that the bacteria can move freely when it is in the planktonic stage, as this 
allows it to move toward optimal conditions for survival. The ability of the cells to 
respond to various environmental cues, and the way they move and orientate 
themselves are therefore vital for survival (Fenchel, 2002). Therefore, motility is one 
of the most crucial mechanisms of the bacteria, and in the following text, we will 
focus on flagellum-based swimming motility.  
2.2.1. The bacteria flagellar apparatus 
The bacterial flagellum is used for swimming in liquid environments and for 
swarming across sub-solid surfaces. It is a complex organelle made up of about 50 
proteins and its assembly and movement are tightly regulated. In general, the 
flagellum consists of three substructures: the basal body, which anchors the flagellum 
to the cell and also embeds the motor that controls the flagellum’s movements; the 
filament, which extend beyond the cell and functions as the propeller; and the hook, 
which connects the filament to the basal body (Fig. 2-5). 
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The basal body is made up of a rod and a series of rings, including an L-ring in the 
outer lipopolysaccharide membrane, a P-ring found in the peptidoglycan layer, as well 
as a membranous and supramembranous MS-ring found within and above the 
cytoplasmic membrane. An additional C-ring extends into the cytoplasm and is made 
up of three proteins FliG, FliM and FliN which control the direction and rotation of 
flagellar rotation. Assembly of the filament occurs by passage of the flagellin subunits 
through the basal body and the hollow flagellar structure (Macnab, 2003). The 
flagellum is also homologous to the type III secretion system (T3SS). 
 
Fig. 2-5. The bacterial flagella apparatus. The flagellum consists of three 
substructures: the basal body, the filament, and the hook, which connects the 
filament to the basal body. The basal body comprising of motor complexes and 
switch proteins is first assembled prior to the assembly of the hook, and later on, the 
filament. This apparatus is also homologous to the type-three secretion system. The 




The flagellar motor consists of proteins that make up the C-ring, and two stator 
proteins, MotA and MotB, which allow protons to pass through and drive flagellar 
rotation. MotB, through its peptidoglycan-binding domain, is attached to the 
peptidoglycan layer, anchoring the stator while MotA interacts with FliG. 
Biochemical data indicate that as protons pass through the MotA and MotB channels, 
a conformational change in MotA takes place (the power stroke), which pushes FliG 
and turns the rotor. MotB is also thought to direct proton movement through the motor, 
and a conserved aspartic acid residue has been shown to be associated with flagellar 
rotation (Kojima and Blair, 2001). It is noteworthy that the structure of the flagellar 
motor may vary in different species. For the case of P. aeruginosa, the flagellar stator 
is made up of two sets of stators instead  (Toutain et al., 2005; Doyle et al., 2004). 
In most bacteria, flagellar assembly is controlled by a strict and sophisticated 
regulatory process. The enteric bacteria E. coli and Salmonella typhimurium have a 
three-tiered transcriptional hierarchy whereas P. aeruginosa and Helicobacter pylori 
have four-tiered systems. For P. aeruginosa, master regulatory flagellar genes encode 
proteins that participate in the flagellar transcriptional circuit. Classes of flagellar 
genes are transcribed sequentially, where the first class includes the transcriptional 
regulator fleQ and fliA that is constitutively expressed. Class II genes, including fleSR, 
are activated by FleQ and RpoN, whereas class III genes are regulated by FleR and 
RpoN. The class IV genes are transcribed upon export of FliA and FlgM through the 
basal body and hook structure, which are assembled from Class II-III gene products. 
This four-tiered transcriptional hierarchy thus results in co-ordinate assembly of the 




2.2.2. Flagellar motor function and its control 
Flagellar rotation about its motor causes bacteria to “swim”. In the well-studied E. coli 
model, when motors turn counter-clockwise (CCW), cells swim in a smooth path 
known as a “run”, whereas when they turn clockwise (CW), they are known to 
“tumble”, which therefore allows bacteria to change direction. The flagellar motor is 
powered by protons passing down an electrochemical gradient across the cytoplasmic 
membrane. The proton (or sodium) motive force generated, in turn, causes flagellar 
rotation. Therefore, with an increase in potential difference, the flagellar rotation 
speeds will also increase (Berg, 2003).  
In order to change the direction of flagellar rotation, phosphorylation of the signalling 
molecule CheY by the kinase CheA first occurs. Phosphorylated CheY then binds to 
FliM of the switching device (C-ring), which causes the rest of the switching device to 
change direction (Wadhams and Armitage, 2004). Such a signalling pathway therefore 
allows the cell to respond to changes in its environment, either to move toward 
advantageous environments or away from unfavourable ones. This behaviour is 
known as chemotaxis (Welch et al., 1993).  
More recently, the membrane-bound protein fumarate reductase (FRD) was also found 
to interact with FliG of the switching device, where the interaction was required for 
switching direction in flagellar rotation and flagellar assembly. Increased fumarate 
levels, through FRD, led to increased flagellar switching and the preference of CW 





2.2.3. C-di-GMP signalling in the control of flagella function 
C-di-GMP signalling affects bacteria flagellar motility at many levels, adding a new 
mode of control to what was previously known about flagellar motility. The levels at 
which c-di-GMP influences flagellar motility include that of transcription, post 
transcription, function, and flagella ejection (Wolfe and Visick, 2008, Fig. 2-6).  
In Vibrio cholerae, overexpression of the DGC CdgF resulted in decreased 
transcription of flagellar genes and other flagellar regulators. This study also suggests 
that the levels of intracellular c-di-GMP and not the natural role of cdgF controls 
flagellar gene transcription as the deletion strain did not alter motility (Beyhan et al., 
2006). Another example of transcriptional control is found in Vibrio parahoemolyticus, 
where the ScrABC operon and ScrG were shown to be required for the transcription of 
lateral flagellar gene FlgEL. Both ScrC of the ScrABC operon and ScrG are hybrid 
GGDEF-EAL domain containing proteins that likely functioned as PDEs since their 
overexpression strains increased intracellular c-di-GMP levels (Ferreira et al., 2008; 
Kim and McCarter, 2007). At the level of post-transcriptional control, TipF, a PDE in 
Caulobacter crescentus was found to influence FljK flagellin levels but not its gene 
transcription levels (Huitema et al., 2006).  
C-di-GMP signalling was also found to affect flagellar motor function. In C. 
crescentus the c-di-GMP effector, DgrA, acts to reduce motility through affecting 
flagellar function and not flagellar synthesis. In the presence of high intracellular 
levels of c-di-GMP, the transcription of FliF, required for flagellar rotation, is reduced 
in the presence of DgrA (Christen et al., 2007).  Another well-studied example where 
c-di-GMP regulates flagellar function is that of the PDE YhjH and c-di-GMP effector 
YcgR in E. coli. First discovered by Ko and Park to be new members of the flagellar 
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regulon, Boehm et al., later showed that adjustment of c-di-GMP levels by the action 
of at least five signalling proteins (including YhjH) can act to fine-tune swimming 
speed through the help of YcgR (Ko and Park, 2000; Boehm et al., 2010). YcgR binds 
c-di-GMP and interacts with the flagellar switch proteins FliG and FliM that in turn 
causes the motor to prefer counter CW rotation and reduces motor output in E. coli 
(Paul et al., 2010).  
 
Fig. 2-6.  C-di-GMP signalling regulates flagellum-based motility. C-di-GMP 
signalling enzymes affect flagellar motility at multiple levels including A-D (mode of 
action is indicated by red arrows). A- Gene transcription. The DGC CdgF decreased 
transcription of flagellar genes while the ScrABC operon encoding PDEs were 
required for transcription of the lateral flagellar gene. B – Post transcriptional. The 
PDE TipF affected levels of FljK flagellin post-transcriptionally. C- Flagellar motor 
function. PilZ-like receptors DgrA and YcgR bind c-di-GMP and in turn control 
flagellar motor function. D – Flagella ejection. The GGDEF domain of the DGC, 
PleD, was required for  proteolysis of FliF that triggers flagellum ejection. 
[Figure adapted from Wolfe and Visick, 2008] 
Lastly, flagellum ejection was also found to be controlled by c-di-GMP signalling. In 
C. crescentus, flagellum ejection occurs when proteolysis of FliF takes place, and the 
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fully functional GGDEF domain of PleD was required for this process, indicating also 
the DGC activity of PleD is important for flagellar ejection (Philip and Jenal, 1999). 
Having observed these diverse ways in which c-di-GMP regulates flagellar motility, it 
is evident that a new paradigm in the control of flagellar motility has emerged. While 
much is already known, there are still important gaps in understanding the 
mechanisms of these signals, and the control of motility in the signalling pathway. 
2.3. Pseudomonas spp. as an emerging model for swimming motility 
2.3.1. Peritrichous Escherichia coli as a model for swimming motility 
Escherichia coli is a gram-negative, rod-shaped enteric bacterium that is commonly 
found in the lower intestines of mammals as part of the normal gut flora. Most E. coli 
strains are not pathogenic, and only a few serotypes are able to cause food poisoning, 
such as the strains O157:H7 and O104:H4 (Griffin and Tauxe, 1991;Woo et al., 2006). 
Of which, the strain O104:H4, detected on raw vegetables, caused the recent outbreak 
of food poisoning in Germany. Since its discovery in 1885 by Theodor Escherich, E. 
coli is now established as a model organism, particularly in the fields of biotechnology 
and microbiology.  
In the field of bacteria motility, the mechanisms which describe how bacteria move 
have been largely studied in E. coli. As a peritrichous bacterium, E. coli on average 
have about 4-5 flagella per cell. In the classical “run” and “tumble” model, a cell “runs” 
or propels forward when all its flagella rotate in the same direction. A cell “tumbles” 
when its flagella switch direction of rotation, and as a result, the flagella spread out to 
allow the cell to “tumble” and reorientate its direction. However, for bacteria, the 
presentation of flagella is widely varied across species in terms of numbers and 
arrangement (Fig. 2-7). How then, do these other types of bacteria move?  
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Fig. 2-7. The presentation of bacteria flagella. The arrangement of bacteria flagella 
fall in to four categories. Monotrichous bacteria have a single flagellum expressed, 
lophotrichous bacteria have a few flagella and are expressed together at a site, 
amphitrichous bacteria have a few flagella expressed at opposite poles of the cell, and 
peritrichous bacteria have a few flagella expressed across its cell surface. [Source: 
Baron, 1996] 
 
2.3.2. Polar monotrichous Pseudomonas aeruginosa  
Pseudomonas aeruginosa is a Gram-negative, rod-shaped aerobic bacterium that has a 
single polar flagellum. It is an opportunistic and nosocomial pathogen that causes 
chronic infection in lungs, cornea and systemic infections in immuno-compromised 
individuals. The virulence determinants of P. aeruginosa are multi-factorial, including 
its ability to inject toxins and proteases into host cells, its secretion of adhesions for 
biofilm formation and persistence in the host, and its adaptability to survive under 
minimal nutrient conditions. In these determinants, the bacteria flagellum plays crucial 
roles, and is required in adhesion, biofilm formation, and also as a virulence factor 
(Lyczak et al., 2000).  
The ability of the cell to migrate toward favourable environments for colonization is 
also dependent on its flagellum. While swimming motility has been well-described in 
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E. coli, little is known for P. aeruginosa. As P. aeruginosa is monotrichous, it is 
likely that its motility is distinct from E. coli. This was supported by the model of a 
‘run’ and ‘reverse’ swim pattern for monotrichous bacteria instead (Mitchell, 2002), as 
the single flagellum gives smaller effects on cell movement comparatively (Fig. 2-8). 
Since swimming motility is likely different in monotrichous bacteria, we therefore 
propose to use P. aeruginosa as a model organism for the study of swimming motility. 
Findings from this study can also be extended to other monotrichous bacteria, of 







Fig. 2-8.  Swimming movements of peritrichous and monotrichous bacteria. A – 
Peritrichous bacteria movements. CCW rotating flagella form a helical bundle 
which rotates and therefore propels the cell forward. CW rotating flagella spread out 
which cause the cell to tumble and reorientate randomly. B – Monotrichous bacteria 
movements. CCW rotating flagellum propels the cell forward, whereas CW rotating 





To date, only indirect methods have been employed to study the flagellar motor 
function in Pseudomonas spp.  Rotation speeds and switch frequency were calculated 
through the analyses of two-dimensional bacteria trails from free swimming cells 
(Taylor and Koshland Jr, 1974; Kuchma et al., 2007). In order to obtain finer details 
and understanding of the flagellar motor function in Pseudomonas spp., the study of 
flagellar rotation and switch frequency directly through cell-tethering assays, a method 
that has been well established for E. coli, may be necessary. 
It is noteworthy that the structure and control of flagellar motility may also be 
different in P. aeruginosa. As earlier mentioned, P. aeruginosa has a two-stator motor 
as compared to one for E. coli, and transcriptional control follow a four-tiered rather 
than three-tiered hierarchy. With regard to control of flagellar switching, P. 
aeruginosa also has four chemotaxis-like signal transduction systems, as compared to 
a single set of che genes in E. coli (Guvener et al., 2006). Having observed differences 
across these levels, it is likely that c-di-GMP signalling and control of flagellar motor 
function may also be different from those earlier described for C. crescentus and E. 
coli.  Establishing the control of flagellar motor function by c-di-GMP signalling in P. 
aeruginosa would therefore be important in understanding Pseudomonas motility. 
2.3.3. Polar multitrichous Pseudomonas putida 
Pseudomonas putida is a Gram-negative rod-shaped saprotrophic soil bacterium that 
is polar multi-flagellated. The strain PNL-MK25 is an antibiotic-resistant derivative of 
the plant growth-promoting rhizobacterial (PGPR) strain ATCC 39169 (Syn, 2004). 
Of any known bacteria species, it has the most number of genes involved in aromatic 
hydrocarbon degradation and is one of the most promising strains to be applied in 
environmental biotechnology. Given the advantages of bioremediation which this 
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strain has, a thorough understanding of its motility phenotype and its control via c-di-
GMP signalling could therefore be useful for developing its applications. 
2.4. Mechanisms of control for output pathways: biofilm development 
2.4.1. Biofilm development in Pseudomonas spp. 
The second lifestyle that bacteria usually exist in is that of biofilms. Biofilms are 
formed on both abiotic and biotic surfaces. They are usually persistent, and can resist 
antibiotic treatment, biocide treatment, and other host immune responses. As biofilms 
may cause significant problems in both the medical and industrial field, a thorough 
understanding of the process of biofilm formation, tolerance development, and biofilm 
dispersal would be relevant to science and other fields. While biofilm formation is 
well described for various bacteria, P. aeruginosa has often been a model organism 
for biofilm research (O'Toole et al., 2000; Harmsen et al., 2010). 
In general, biofilm development occurs in five stages (Fig. 2-9), that of attachment, 
irreversible attachment, early biofilm development, biofilm maturation, and dispersal 
(Karatan and Watnick, 2009). Firstly, for biofilm attachment, adhesive structures are 
required, of which some include bacteria flagella, pili, and other adhesins that are 
conditionally synthesized, or specific for host cell attachment. This first stage of 
attachment allows a monolayer of cells to be formed and initiates subsequent 
development of the biofilm. 
The subsequent stage of biofilm formation involves that of extracellular polymeric 
substances (EPS), where a layer of slime-like substances composing of 
polysaccharides, proteins, and extracellular DNA (eDNA), are produced. This causes 
‘irreversible attachment’ of the cells to the surface, and also provides the structural 
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support for further development of the biofilm (Branda et al., 2005). In P. aeruginosa, 
eDNA was found to be a key component for this attachment of biofilms (Whitchurch 
et al., 2002).  Additionally, the EPS produced also confer many properties to the 
biofilm and enables it to further develop and mature. 
During its development and maturation, the cells in the biofilm aggregate and the EPS 
forms a hydrated polymer network (the biofilm matrix), where many different 
processes take place. Cell-cell communication (quorum sensing), is a key process that 
coordinates EPS production and cell differentiation in the biofilm structure as the 
biofilm matures (Jayaraman and Wood, 2008). Active nutrient acquisition takes place 
through sorption of organic compounds, as well as digestion of exogenous 
macromolecules by EPS enzymes (Flemming and Wingender, 2010). The exchange of 
genetic information between cells in the biofilm also occurs through extracellular 
DNA (eDNA), and is believed to be important in transferring resistance genes (Fux et 
al., 2005). A protective barrier made of polysaccharides and proteins which confer 
resistance to host defences and tolerance to antimicrobial agents is also formed. The 
fully-developed biofilm typically adopts a mushroom-like macroscopic structure. In P. 
aeruginosa biofilms, eDNA was found to be present in high concentrations at the 
stalks of the mushroom-shaped microcolonies (Allesen-Holm et al., 2006), suggesting 
that eDNA might have facilitated the development of the macroscopic mushroom-like 
structure. 
Following biofilm maturation, dispersal takes place when the conditions for the 
biofilms no longer remain ideal. For example, as biofilms grow in size, the innermost 
layers of the biofilms may not have access to nutrients or may be exposed to too much 
waste products, causing their microenvironments to be unfavourable. Changes in the 
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biofilm environment may also cause bacteria in the sessile form to enter into a 
planktonic lifeform. When the biofilms sense these changes, a highly regulated 
process involving different sensory circuits will result in biofilm dispersal.  
 
Fig. 2-9. The biofilm development process. The five stages include 1- initial 
attachment of cells, 2- production of EPS resulting in irreversible attachment, 3- 
early development of biofilm structure, 4- maturation of biofilm architecture, 5- 
dispersion of single cells from the biofilm. The bottom panels (a-e) show each of 
the five stages of development represented by photomicrographs of P. aeruginosa. 





2.4.2. Role of c-di-GMP signalling in the control of biofilm formation 
In the biofilm development process, the role for c-di-GMP in controlling biofilm 
formation was first suggested in SrcABC, where a GGDEF-EAL domain-containing 
protein in the operon affected biofilm formation (Boles and McCarter, 2002). Gene 
deletions in SrcABC resulted in decreased swarming motility and increased capsular 
polysaccharide (CPS) production and, in turn, increased biofilm formation. The first 
direct study linking levels of c-di-GMP to biofilm formation was described in V. 
cholerae, where expression of a DGC increased intracellular levels of c-di-GMP that 
resulted in increased expression of V. cholerae exopolysaccharides required for 
biofilm formation (Tischler and Camilli, 2004). The opposite effect was observed 
when a PDE was expressed.   
Following these findings, many others have elucidated the role of c-di-GMP in 
different stages of biofilm development (Romling and Amikam, 2006).  For the initial 
stage of biofilm formation, biofilm attachment is a key step which involves bacterial 
appendages and adhesions. Fimbriae expression (CupA fimbriae), which is required 
for attachment, is positively regulated by GGDEF-domain containing proteins 
PA1120 (Meissner et al., 2007). Overexpression of the EAL-domain containing 
protein PvrR, in contrast, reduced fimbriae expression. LapA, an adhesin that is 
required for the transition from reversible to irreversible attachment, is also regulated 
by c-di-GMP signalling. The PDE RapA was found to reduce intracellular c-di-GMP 
that thus inhibits the secretion of LapA (Monds et al., 2007).   
Components of the biofilm matrix, which is essential for development and maturation 
of the biofilm, are also affected by c-di-GMP signalling enzymes. For example, the 
DGC SadC is required for EPS production and a deletion in SadC results in a 
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hyperswarmer phenotype (Merritt et al., 2007). On the contrary, the PDE BifA was 
required for motility and a deletion in BifA resulted in increased synthesis of EPS 
production (Kuchma et al., 2007). Similar to these examples, other cases of regulation 
of EPS production by c-di-GMP signalling have also been described (Tagliabue et al., 
2010; Hickman, 2005;Merritt et al., 2010). Levels of c-di-GMP also affect production 
of eDNA, where decreased c-di-GMP levels were shown to increase eDNA 
production (Ueda and Wood, 2010).  
In addition, biofilm dispersal was shown to be regulated by levels of c-di-GMP. Nitric 
oxide-stimulated PDE activity was shown to reduce c-di-GMP levels that in turn 
promoted biofilm dispersal (Barraud et al., 2009). The PDE, RbdA also promotes 
biofilm dispersal through two effects, firstly in downregulating biofilm formation and 
secondly, in upregulating production of the factors associated with biofilm dispersal 
(An et al., 2010).  
As observed, c-di-GMP signalling plays an important role in different stages of 
biofilm development and regulates different processes that allow the transition of cells 
from a motile to sessile lifestyle. While much is already known, the coordinated 
control of these signalling processes remains to be elucidated. Given the large number 
of GGDEF and EAL domain-containing proteins found in a genome, the role of these 
proteins in regulating motility and biofilm formation remain to be discovered. Thus, a 
further understanding of the role of c-di-GMP signalling in the Pseudomonas spp. 




2.5. MorA- A global sensor-regulator of motility and biofilm formation in 
Pseudomonas spp.  
Previously, we have described a novel membrane-localized regulator, MorA, which 
controls the timing of flagellar development, affects motility, chemotaxis, and biofilm 
formation in P. putida. MorA is conserved among diverse Pseudomonas species, and 
homologues are present in all Pseudomonas genomes sequenced thus far. Members of 
the Pseudomonas MorA family are present as single copies in the genome, are 
membrane localized due to the transmembrane domains, possess a central sensory 
domain consisting of PAS-PAC motifs, and have C-terminal GGDEF and EAL 
domains (Choy et al., 2004).  
Absence of MorA derepresses flagellar development in P.putida, which leads to 
constitutive formation of flagella in the mutant cells in all growth phases (Fig. 2-10A). 
Precocious production of flagella correlated with a reduction in biofilm formation (Fig. 
2-10B).  In P. aeruginosa, however, the absence of MorA led to a reduction in biofilm 
formation (Fig. 2-11B), and there was no hyperflagellation observed (Fig. 2-11A). 
Also, in P. putida morA knockout cells, the transcription level of flagellin was 
increased as compared to wild-type cells, but this was not described for P. aeruginosa 
(Choy et al., 2004). Differences in the control of motility by MorA in the two species 
have been addressed in more detail in this study, as reported in Chapter 4 and Chapter 
6. These results thus indicate that MorA involvement in the flagellum pathway is 
different in the two species.  
It is likely that MorA, similar to other GGDEF and EAL domain-containing proteins, 
regulates these described functions in Pseudomonas spp. through altering c-di-GMP 
levels. However, functional characterization of this GGDEF-EAL bidomain protein 
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remains to be done. Previous attempts in enzymatic and structural studies of 
recombinant MorA were unsuccessful due to protein insolubility (Lye 2006). Hence, 
understanding the biochemical role of MorA would shed light on how GGDEF-EAL 
bidomain proteins regulate c-di-GMP levels and, in turn, biological outcomes. 
The MorA system in Pseudomonas spp. therefore provides two elements in the 
investigation. Firstly, it is a bidomain GGDEF-EAL signalling protein, and secondly, 
at least two biological functions have been shown to be controlled by c-di-GMP 









Fig. 2-10. Flagella phenotype in P.putida morA knockout and wild-type strains. 
A- Trans-Electron Microscopy (TEM) of cells. Hyperflagellation phenotype in 
morA knockout is observed throughout all growth phases. B- Biofilm formation. 
morA knockout strains form less biofilms. This correlated with the hyperflagellation 








Fig. 2-11. Flagella phenotype in P. aeruginosa morA-Pa knockout and wild-type 
strains. A- TEM of cells. TEM revealed absence of hyperflagellation phenotype in 
P. aeruginosa. B- Biofilm formation. morA-Pa knockout strains form less biofilms. 
These results indicate that MorA affects flagella pathway in P.putida and 













3. Materials and methods 
3.1. Bacterial strains, plasmids, and media 
Bacterial strains and plasmids used in this study are described in Table 3-1. E. coli and 
P. aeruginosa PAO1 strains were grown routinely in Luria-Bertani (LB) medium at 
37°C with suitable antibiotics (Table 3-1). P. putida strains were grown routinely in 
LB medium at 30oC with suitable antibiotics (Table 3-1). Bacterial growth was 
measured spectrophotometrically at OD600. 
3.2. Generation of soluble recombinant MorA (rMorA) 
3.2.1. Creating constructs for expressing catalytic fragments of MorA 
Partial morA gene fragments, excluding the insoluble transmembrane domain, were 
amplified from pGB1-PpMorA (Choy et al, 2004) for cloning into C-terminus or N-
terminus His6-tagged protein expression vectors. The list of primers, and 
corresponding fragments, restriction sites, and vectors used are presented in Table 3-2. 
PCR amplification was performed using pfu polymerase (Fermentas, USA), and 
products were cloned into a modified C-terminus His6-tagged pET-32 expression 
vector (Novagen, Germany) in which its Trx-tag had been deleted. The resultant 
constructs were then verified by using sequencing vector primers T7-terminator and 
SP6, with the BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies, 
USA) according to the manufacturer’s instructions. Constructs were then introduced 
into E. coli BL21 cells for protein expression. 
The creation of recombinant protein fragments was performed with the guidance and 
help of Dr. Huang Weidong. 
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Table 3-1. Bacterial strains and plasmids 
Strain/ plasmid  Relevant characteristics1 Source  







Wild-type P. putida strain; Cmr  Rfr 
 
PNL-MK25 mutant (morAPp::aacC1); Cmr Rfr Gmr 




Choy et al., 
Ng, W.L. & 
Swarup, S. 





Wild-type P. aeruginosa PAO1 strain  
PAO1 mutant (morAPa::aacC1); Gmr 
PAO1 markerless morA deletion 
 
Das gupta et al.,
Choy et al., 









Plasmids   
pET PleD Protein expression plasmid containing full-length 
PleD; Ampr
Jenal, U. 
pET CC3396 Protein expression plasmid containing full-length 
CC3396; Ampr
Jenal, U. 
pET tDGC Protein expression plasmid containing full-length 
tDGC; Kmr
Liang, Z.X. 
pET rMorA Protein expression plasmid containing catalytic 
fragment of MorA; Ampr
This study 
pET E929K pET rMorA with E929K mutation; Ampr This study 
pET E1058K pET rMorA with E1058K mutation; Ampr This study 
pET  L1060G pET rMorA with L1060G mutation; Ampr This study 
pET rMorA-Pa Protein expression plasmid containing catalytic 
fragment of MorA-Pa; Ampr
This study 
pMorA Full-length morAPp gene with its native promoter 
cloned into pGB1; Ampr  Tetr
Choy et al., 
pE929K pGB1morA with E929K mutation; Ampr  Tetr This study 
pE1058K pGB1morA with E1058K mutation; Ampr  Tetr This study 
pL1060G pGB1morA with L1060G mutation; Ampr  Tetr This study 
pUPMR pUCP19morA, Full-length morAPa gene with its 
native promoter cloned into pUCP19; Cbr
Choy et al., 
pUPMR P* pUPMR with A352V mutation; Cbr Choy et al.,
pUPMR a P*K* pUPMR with A352V and E1160K mutation; Cbr This study 
pUPMR P*G* pUPMR with A352V and E1189K mutation; Cbr This study 
pUPMR K* pUPMR with E1060K mutation; Cbr This study 
pUPMR G* pUPMR with E1189K mutation; Cbr This study 
1Cm, chloramphenicol 15 µg/ml; Rf, rifampicin 20 µg/ml; Km, kanamycin 15 µg/ml; 
Gm, gentamycin 20 µg/ml (PNL-MK25) or 100 µg/ml (PAO1); Amp, ampicillin 100 
µg/ml; Tet, tetracycline 25 µg/ml.  
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Table 3-2. List of primers used for generating constructs 
Primers  Forward (5’-3’)  Reverse (5’-3’) 
Sequence Site1 Sequence Site1 
Protein expression2 
























MorA Reverse  
E1058K_ 
Forward 








MorA Reverse  
L1060G_ 
Forward 










MorA Reverse  
Site-directed mutagenesis 






















































TCAGCCCTCG TTGAACATG 4248- 
4230 
1Primer-binding sites of the nucleotide sequences of MorA (GenBank: AAP85527.1) 
or MorA-Pa (GenBank: AAG07989.1). The primer regions that bind to the template 
are indicated in bold. 
2Protein expression clones were cloned into pET32 at the BamHI (Forward) and 
HindIII (Reverse) restriction sites. 




3.2.2. Testing of catalytic protein expression clones for yield and solubility 
Escherichia coli BL21 cells transformed with the protein expression plasmids were 
grown using overnight seed cultures at 37oC, 200 rpm, until OD600 reached 0.8. 
Induction was carried out by the addition of 0.1 mM IPTG overnight at 20oC, 200 rpm. 
Bacterial cells were then harvested and recombinant protein expression was verified 
through SDS-PAGE analyses using a 10% SDS-PAGE gel and Coomassie blue stain 
(Sambrook et al., 1989). Bacterial cells containing expressed proteins were then lysed 
by sonication in lysis buffer containing 300 mM NaCl, 50 mM NaH2PO4, 20 mM 
Imidazole and 1% Triton-X, pH 8.0. Soluble and insoluble protein fractions were 
separated by centrifugation at 12 000 rpm for 1 h, and recombinant MorA (rMorA) 
proteins were examined for solubility by SDS-PAGE analyses. 
3.3. Generation of mutations for residue replacements in GGDEF and EAL 
motifs of MorA 
3.3.1. Site-directed mutagenesis for expression of GGDEF and EAL mutants  
To generate site-directed mutations of rMorA, primers were used to introduce the 
respective mutations in partial gene fragments, which were subsequently fused 
together via PCR amplification using Forward and Reverse MorA primers (primer 
combinations in Table 3-2). Amplicons carrying these mutations were cloned into 
pET32a via restriction digest sites and ligation (Fermentas, USA). The pET32a 
plasmids were subsequently introduced into E. coli BL21 cells for recombinant 
protein expression.  
For the generation of site directed mutants for expression in P. aeruginosa strains, the 
above method was used with Forward and Reverse MorA-Pa primers (primer 
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combinations in Table 3-2). Amplicons carrying these mutations were cloned into 
plasmids pUPMR and pUPMR P*. The pUPMR plasmids were subsequently 
introduced into P. aeruginosa PAO1 wild-type and ΔmorA strains. 
The generation of GGDEF and EAL site-directed mutant strains for protein expression 
was performed with the help of Dr. Huang Weidong. The generation of P. aeruginosa 
site-directed mutants was performed with the help of Mr. Wong Junjie and Mr. 
Dickson Sng. 
3.3.2. Site-directed mutagenesis for expression of GGDEF and EAL mutants in 
P. putida strains 
For generation of P. putida plasmids, site-directed mutagenesis was performed on 
pGB1MorA using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent 
Technologies, USA) with same primers as described for generation of recombinant 
proteins. The plasmids were subsequently introduced into P. putida PNLMK25 wild-
type and ΔmorA markerless knockout strains. These strains were similar in phenotype 
to the gentamycin insertion knockout strain, morAPp. 
The generation of GGDEF and EAL P. putida site-directed mutants was performed 
with the help of Ms. Ng Weiling. 
3.3.3. Verification of site-directed mutant clones 
Plasmids obtained from site-directed mutagenesis were routinely sequence-verified 
using the BigDye Terminator v3.1 Cycle Sequencing Kit (Life Technologies, USA). 
Electropherograms were analyzed for the correct nucleotide mutations. Their 
corresponding amino acid sequences were translated to verify the clones (Fig. 3-1). 
The full list of sequence-verified site-directed mutants can be found in Appendix I.  
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Fig. 3-1. Verification of site-directed mutant clones. Protein expression pE929K 
vector was sequence verified. The top panel shows the sequence of the original pUPMR 
plasmid, the bottom panel shows the E to K mutation at E929.  
 
During the screening process, a PCR error-based mutant was identified at A352 of the 
first PAS domain of pUPMR where an alanine residue was substituted for valine (Fig 
3-2). The plasmid carrying the PAS mutation, pUPMR P*, was used for subsequent 
analyses. GGDEF and EAL mutations were also introduced in pUPMR P* as 







Fig. 3-2. PCR error-based mutation in PAS domain of pUPMR. A- 
Electropherograms of pUPMR with an A352V mutation. The top panel shows the 
sequence of the original pUPMR plasmid, the bottom panel shows the A to V 
mutation at A352. B- A352V is located at the first PAS domain of MorA. Domain 
analysis of full-length MorA locates the A352V mutation at the first PAS domain as 
indicated by the red star. 
 
3.4. Characterization of rMorA 
3.4.1. Large-scale expression and purification of rMorA 
The soluble fractions containing recombinant proteins were loaded onto columns 
containing Ni-NTA affinity resin (Qiagen, Germany). The columns were washed with 
buffer, and recombinant proteins were eluted with imidazole as recommended by the 
manufacturer. Protein preparations were examined for purity by SDS-PAGE and 
fractions containing pure protein were pooled used for downstream analyses. The 
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expression and purification of recombinant proteins were scaled-up and performed 
routinely for various experimental purposes. 
3.4.2. Buffer optimization for rMorA 
As the rMorA proteins were used for analyses such as isothermal titration calorimetry 
(ITC) and crystallization (for a separate study), it was important to establish a suitable 
buffer condition for rMorA to perform these experiments such that protein solubility 
will not be compromised. The buffers were tested using decreasing concentration of 
NaCl, NaH2PO4 or Tris-HCl, and in the pH range of 7.0-7.5. The salts and pH were 
selected for optimization as they did not cause precipitation when added to the soluble 
protein in a preliminary test. Purified proteins were thus dialysed twice overnight in 
various buffers and soluble fractions were electrophoresed (Table 3-3). Buffer 8 was 
the optimal buffer chosen (Results in Chapter 5.1.2, Figure 5-2). 
Table 3-3. List of buffers tested for rMorA solubility 
No. Buffer Salt Concentration pH
1 1 X Elution buffer (EB) without 
imidazole 
300mM NaCl, 150mM NaH2PO4 7.5 
2 0.5 X EB without imidazole 150mM NaCl, 75mM NaH2PO4 7.5 
3 50 mM Sodium phosphate buffer 50mM NaH2PO4 7.0 
4 25mM Sodium phosphate buffer 25mM NaH2PO4 7.0 
5 25mM Tris buffer 25mM Tris-HCl 7.0 
6 1X Phosphate buffered saline 
(PBS) 
137mM NaCl, 10mM NaH2PO4, 
 2.7mM KCl 
7.4 
7 0.5 X PBS 68.5mM NaCl, 5mM NaH2PO4,  
1.35mM KCl 
7.4 





3.4.3. Circular dichroism (CD) spectroscopy 
Far-UV circular dichroism (CD) spectra (260–190 nm) were recorded using a Jasco J-
810 spectropolarimeter and measurements were carried out at room temperature using 
0.1 cm path length cuvettes. The instrument optics were flushed with 25 L of nitrogen 
gas/min. Spectra were recorded using a scan speed of 50 nm/min, a resolution of 0.2 
nm, and a bandwidth of 2 nm. Five scans were recorded and averaged for each 
spectrum, and the base line was subtracted. The CD spectra of rMorA and its 
substrate-bound forms were recorded in 150 mM NaCl, 75 mM Tris-HCl (pH 7.5).  
CD spectra data was analyzed using the K2D tool (Andrade et al., 1993). 
3.4.4. Dimerization assays using size-exclusion chromatography (SEC) 
Purified protein (10 µM) was subjected to size-exclusion chromatography (SEC) using 
a Superdex 200 10/300 column (GE Healthcare, USA) equilibrated in gel filtration 
buffer (10 mM MgCl2, 75 mM Tris-HCl, 150 mM NaCl, pH 7.5. Detection at 280 nm 
was performed using High Performance Liquid Chromatography (HPLC) with an 
ÄKTA Purifier 10 System (GE Healthcare, USA) at room temperature, using a flow 
rate of 0.5 ml/min. Dimerization assays for rMorA and its three mutants were 
performed using PleD as a control since it has a similar size to rMorA (~50kDa) and is 
known to dimerize (Chan et al., 2004). 
3.4.5. Isothermal titration calorimetry (ITC) 
 The interaction of rMorA proteins with GTP was monitored with a VP-ITC titration 
calorimetric system (MicroCal, USA). The instrument was calibrated using the built-
in electrical calibration check. Proteins (10µM) in a suitable buffer (150 mM NaCl, 75 
mM Tris-HCl, 500 mM imidazole pH 7.5) were injected in the calorimetric cell and 
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titrated with the GTP (200 µM) dissolved in the same buffer in a 250 µl injection 
syringe with continual stirring at 240 rpm at 25 °C. All protein solutions were filtered 
and degassed prior to titration. The first injections that presented defects in the 
calorimetric data were processed and fitted to the single set of identical sites model 
using MicroCal Origin (Version 7.0) data analysis software supplied with the 
instrument. The total heat content (Q) of the solution (determined relative to zero for 
the unliganded species) contained in the active cell volume (V1) was calculated 
according to Equation 1 (Chen and Wadsö, 1982),  
 
- Equation 1 
where K is the binding affinity constant; n is the number of sites; ΔH is the enthalpy 
of ligand binding; and Mt and Xt are the bulk concentrations of macromolecule and 
ligand, respectively, for the binding X + M  XM. The change in heat (ΔH) 
measured between the completions of two consecutive injections is corrected for 
dilution of the protein and ligand in the cell according to standard Marquardt methods. 
The free energy change (ΔG) during the interaction was calculated using the 
relationship  ΔG = ΔH - TΔS = -RT ln Ka, where T is the absolute temperature and R 
is the universal gas constant. 
  
 Xt  1  4Xt 
             nMt nKuMt  nMt 
nM1ΔHV1       Xt                1 
       2                   nMt           nKuMt 
Q= ( 1+             +                  )  
       
     
-  √( 1+             +                  )2   -
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3.5. Catalytic reactions 
3.5.1. Enzymatic synthesis of c-di-GMP 
Enzymatic synthesis of c-di-GMP was performed using tDGC (Rao et al., 2009) and 
c-di-GMP was purified by HPLC using an ÄKTA Purifier 10 System (GE Healthcare, 
USA). Crude fractions of 1 ml each containing ~1mM c-di-GMP was passed through 
a semi-preparative Jupiter Proteo C18 (10 mm x 250 mm) column (Phenomenex, 
USA). A flow rate of 5.0 ml/min with isocratic elution of 10% methanol and 90% 20 
mM triethyl ammonium bicarbonate (TEAB) was used. Purified c-di-GMP eluted at 
~20 min and eluates of ~15ml each was collected per run. Eluates of c-di-GMP were 
then lyophilized and dissolved in water for use. The identity of c-di-GMP was 
confirmed using HPLC and Mass Spectrometry (MS) where purified c-di-GMP was 
compared with commercial c-di-GMP (Biolog, Germany). The procedures for HPLC 
and MS are described in Chapter 3.5.5 and Chapter 3.8, respectively.  A total volume 
of 30 ml crude c-di-GMP was purified, and a final 300 µl stock of ~10mM c-di-GMP 







Fig. 3-3 Enzymatic synthesis of c-di-GMP. The identity of c-di-GMP purified from 
enzymatic preparations was verified and compared with commercial c-di-GMP standards. A – 
HPLC of c-di-GMP standard. B – HPLC of purified c-di-GMP from enzymatic 
preparations. HPLC profiles of c-di-GMP prepared from enzymatic synthesis and 
commercial c-di-GMP standards are similar (c-di-GMP was detected at 20.5 min). C – MS of 
c-di-GMP standard. D – MS of purified c-di-GMP from enzymatic preparations MS 
profiles of c-di-GMP prepared from enzymatic synthesis and commercial c-di-GMP standards 
are similar (m/z =688.8). Note that the concentration of c-di-GMP purified from enzymatic 
preparations is high. 
 
3.5.2. Diguanylate cyclase (DGC) assay 
Purified recombinant MorA fractions (10 µM), were incubated at 25oC with 200 µM 
GTP for 2 h in 10 mM MgCl2, 150 mM NaCl, 75 mM Tris-HCl (pH 7.5). The reaction 
was stopped by heat precipitation at 95oC for 5 min and proteins were removed by 
centrifugation at 14 000 rpm, 4o C, 10 min. Supernatants were then filtered using 0.2 
µM Minisart 17821Q cellulose filters (Sartorius, France) before passing them though 
HPLC for nucleotide determination and quantitation. For cofactor analyses, MgCl2 
was replaced with 10 mM of CaCl2, ZnCl2, or KCl. For phosphorylation assays, 
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rMorA was incubated with 10 mM acetyl phosphate for 20 min prior to addition of 
GTP. For GTPγS reactions, 200 and 600 µM GTPγS was used, instead of GTP. For 
determining kinetic parameters, a range of 0-600 µM GTP was used. The reactions 
were performed in triplicates and the experiments are repeated twice. 
3.5.3. Phosphodiesterase (PDE) assay 
Purified recombinant MorA fractions (10 µM), were incubated at 25oC with 50 µM c-
di-GMP for 2 h in 10 mM MgCl2, 150 mM NaCl, 75 mM Tris-HCl (pH 7.5). The 
reaction was stopped by heat precipitation at 95oC for 5 min and proteins were 
removed by centrifugation at 14 000 rpm, 4oC, 10 min. Supernatants were then filtered 
using 0.2 µM Minisart 17821Q cellulose filters (Sartorius, France) before passing 
them though HPLC for nucleotide determination and quantitation. The reactions were 
performed in triplicates and repeated twice. 
3.5.4. DGC product inhibition assay 
For DGC inhibition assays, purified proteins (10 µM) were pre-incubated in 10 mM 
MgCl2, 75 mM Tris-HCl (pH 7.5) and 500 mM NaCl with 0-100 µM c-di-GMP for 20 
min before addition of 200 µM GTP. After incubation for 2 h, the reaction was 
stopped by heat precipitation at 95oC for 5 min and proteins were removed by 
centrifugation at 14 000 rpm, 4oC, 10 min. Supernatants were then filtered using 0.2 
µM Minisart 17821Q cellulose filters (Sartorius, France) before passing them though 
HPLC for nucleotide determination and quantitation. 
3.5.5. Detection and quantitation of c-di-GMP from enzymatic reactions 
Nucleotides (60 µl) that were filtered from the enzymatic reactions were separated 
using reversed-phase HPLC with a 250×4.6 mm Jupiter 5µ C18 300Å column 
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(Phenomenex, USA) at 30oC. Runs were carried out for 30 min with isocratic elution 
(0.75 ml/min) using 95% 20 mM triethylammonium acetate (TEAA) buffer pH 7.0 
and 5% of methanol. Nucleotides were identified by comparing HPLC elution profiles 
against known standards. Product fractions of DGC and PDE assays were collected 
and masses of the nucleotides were confirmed using MS (procedure described in 
Chapter 3.8). Nucleotide concentrations of GTP and c-di-GMP were then ascertained 
by calculating the area under curve against a standard curve of known concentrations 
using Chemstation (Agilent Technologies, USA). For product inhibition assays, c-di-
GMP concentration produced was determined by subtraction of final and initial c-di-
GMP concentrations. 
3.5.6. Analysis of enzyme kinetic parameters 
Initial velocities were determined and kinetic curves were plotted using Equation 2 
(Motulsky and Christopoulos, 2003),    
  
- Equation 2 
where Vo is the rate of DGC activity expressed in nM c-di-GMP produced/µM 
protein/min, Vmax is the maximum of Vo, S is the GTP concentration (µM) and Km is 
the Michaelis-Menten constant. The catalytic constant, Kcat, is a thus a measure of 
Vmax/Et expressed in units of inverse time, where Et is the enzyme concentration. For 
DGC inhibition assays, the dose–response curve was obtained using Equation 3 
(Motulsky and Christopoulos, 2003),  
   Vo = 
  Vmax [S] 
  Km + [S]     
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-         Equation 3 
where X is the inhibitor concentration and Y is the specific activity. The bottom 
and top refer to the baseline and maximum response, respectively, of the dose-
response as determined by the inhibition.  
3.6. In silico three-dimensional modelling of rMorA 
The structural model for the GGDEFMorA domain was constructed using the Swiss-
Model Server (Arnold 2006;Kiefer et al., 2009) with the coordinates of the PleD 
structure (Protein Data Bank, PDB ID: 2V0N) as a template. Domain boundaries for 
modelling were determined by the Simple Modular Architecture Research Tool 
(Schultz et al., 1998; Letunic et al., 2009). Using Swiss-Model, we also constructed 
the EALMorA domain using the coordinates of the tdEAL structure (PDB ID: 3n3t). Co-
ordinates of c-di-GMP, GTP, and Mg2+ for GGDEFMorA, and c-di-GMP for EALMorA 
were also taken from their corresponding PDB IDs. Sequence similarity for 
GGDEFMorA and PleD was 35% whereas EALMorA and tdEAL was 46% (Appendix II). 
3.7. Intracellular extraction of c-di-GMP using acid-hydrolysis 
Intracellular c-di-GMP was extracted from 250 ml of P.putida cells (grown in LB 
media, at OD600=1.6) using 1 ml 0.6 M HClO4.  Nucleotide extracts were neutralized 
with 0.5 M K2CO3 to pH 6.5 and filter-sterilized prior to analysis using Electronspray 
Ionization-Mass Spectrometry (ESI-MS). Nucleotides were extracted from three 
clones for each strain, and the extractions were performed two times per clone. 
  
Y = 
 bottom + (top − bottom) 
          (LogIC50 − X)  1 + 10 
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3.8. Detection and quantitation of c-di-GMP  
Enzymatic and intracellular nucleotide extracts were analyzed in an ABI MDS SCIEX 
4000Q Trap System (Applied Biosystems, USA) using an Electronspray Ionization 
(ESI) probe at the Tropical Marine Science Institute (Singapore).  Mass spectrometry 
was carried out in the negative mode for 300–750 m/z using an isocratic mobile phase 
of acetonitrile and 0.1% acetic acid water at a flow rate of 250 µl/min.  Each sample 
(14 µl) was injected three times and runs were performed for 2.5 min, using a 
diassociation energy of 81 volts and source voltage 4400 volts at 250oC. For 
intracellular extracts, a precursor ion scan of intracellular c-di-GMP gave major ions 
of 139.9, 195.8 and 253.2 m/z. These ions were subsequently used for multiple-
reaction monitoring (MRM) analyses. 
For MRM analyses, a standard curve was obtained using intracellular nucleotide 
extracts that were spiked with 0-200 µM c-di-GMP. MRM was performed with 
collision energy of 39 volts, and each scan was fixed for 3 sec for 2.5 min. The ions 
139.9, 195.8 and 253.2 m/z were tracked, and count intensities were subtracted from 
the original nucleotide mixture to ascertain values for the standard curve. Nucleotide 
samples were then tracked using the same method and c-di-GMP was quantitated 
using the standard curve. 
3.9. Swimming motility assays 
3.9.1. Motility plate assays 
For P. putida cells, overnight cultures were diluted to OD600=0.1 prior to inoculation 
in motility agar plates as previously described (Choy et al., 2004). After incubation for 
30 h at 30°C, the movement of the bacteria away from the inoculation point was 
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determined relative to the movement of wild-type P. putida cells. For P. aeruginosa, 
overnight cultures were diluted to OD600=0.1 prior to inoculation in 0.3 % w/v bacto 
agar (BD Biosciences, USA). After incubation for 16 h at 37°C, the movement of the 
bacteria away from the inoculation point was determined relative to the movement of 
wild-type P. aeruginosa cells. 
3.9.2. Single-cell motility speed assays 
For tracking of bacterial speeds, overnight cultures were diluted to OD600=0.1 in LB 
media and grown to their desired growth phases prior to imaging. Chambers (0.8 cm x 
0.8 cm) with depths of 100 µm were created using two layers of double sided tape 
between the microscope slide and coverslip. Cells were diluted to cell densities for 
optimal tracking (~OD600=0.2) and 60 µl of cell suspension was loaded in the chamber 
for imaging. A Nikon Eclipse E600 microscope (Nikon, Japan) was used for 
visualizing the cells under a 60x Plan Apo air lens (Nikon, Japan) and image capture 
was carried out using a QICAM 12-bit CCD camera (QImaging, Canada). Movies 
were taken in AVI format for 20 s at 10 fps. At least two videos were taken per strain. 
3.9.3. Image analyses 
Single-cell bacterial speeds were tracked using Image-Pro Plus 6.3 (Media 
Cybernetics, USA). Speeds were tracked for motile cells using the following 
thresholds: cells were considered motile if they moved faster than 2.0µm/s, and only 
cells that travelled for a length of 3.0µm on the videos were used. Speeds of 100 cells 
from two separate videos were taken per strain and the average speeds were analyzed 
using Graphpad Prism 5.0 (Graphpad Software, USA). The variances of speeds 
differed from each other using one-way ANOVA, and significant differences (p>0.05) 
were analyzed using Tukey’s pairwise comparison of means.   
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Two-dimensional trajectories were obtained by plotting X-Y coordinates of the cells 
from 20 s videos, and turn angles were ascertained using Image-Pro Plus 6.3 (Media 
Cybernetics, USA). 
3.10. Analyses of flagellar rotation 
3.10.1. Generation of P. putida and P. aeruginosa anti-flagellin antibodies 
Cell cultures of P. aeruginosa and P. putida were grown for 24 h at 37 oC and 30 oC 
respectively.  Cells were harvested, washed, and solubilized in 20ml water before 
flagella was sheared-off by passing the cells through a 23 ½ gauge needle 10 times. 
Cells were then centrifuged at 10000 g for 1 h. Supernatants containing the flagellin 
were removed and centrifuged at 50000 g for 2 h. The pellets containing flagellin were 
then redissolved in water and the pH was adjusted to 2.0. The redissolved pellets were 
then centrifuged at 50000 g for 2h. Supernatants containing the flagellin were then 
lyphollized and redissolved in 500µl of water. The flagellin preparations were next 
checked for size and purity by SDS-PAGE. 
Flagellin extracted from P. aeruginosa PAO1 corresponded to FliC (PA1052), with a 
size of ~50 kDa (Fig. 3-4A). As the genome sequence for PNL-MK25 is not available, 
flagellin extracted from P. putida PNL-MK25 was compared to flagellin from the 
related P. putida GB-1 strain. The extracted flagellin, with a size of ~25 kDa, was 
similar to the GB-1 flagellin protein (Pput1489, Fig. 3-4B). The typical yield for 1 L 
cultures of P. aeruginosa and P. putida were 1.0 mg and 0.3 mg of flagellin 
respectively. A total of 1.5-2.0 mg of flagellin was collected for antibody production 
in rabbits by 1st BASE Antibodies (1st BASE, Singapore). The flagellin antibody from 





Fig. 3-4. Flagellin preparations of Pseudomonas cells. A – P. aeruginosa flagellin. 
Lanes 1-3: 1µg/µl BSA control, marker, and flagellin extracted from PAO1. High 
concentrations of flagellin were extracted from PAO1. The ~50kDa protein 
corresponded to FliC (49 kDa) flagellin protein. B – P. putida flagellin. Lanes 1-3: 
1µg/µl BSA control, marker, and flagellin extracted from PNL-MK25. Lower 
concentrations of flagellin were extracted from PNL-MK25. The ~25kDa protein 
corresponded to the flagellin protein (Pput1489) from the related GB-1 strain. 
 
3.10.2. Cell-tethering assays 
Overnight P. aeruginosa cultures were diluted to OD600=0.1 in LB media and grown 
to their desired growth phases prior to imaging. Flagellin was sheared off from the 
cells by passing the cultures 8 times through a 23 ½ gauge needle. Cells were diluted 
and placed on coverslips precoated with poly-L-lysine and flagellin antibody (1:100).  
To allow tethering of the cells, cell cultures were incubated on the coated coverslips 
for 10 min at 37oC. Unbound cells were removed by rinsing with LB and the 
coverslips were then used to form 100 µm-deep chambers as previously described in 





3.10.3. Image analyses 
Rotation speeds were tracked manually using Image-Pro Plus 6.3 (Media Cybernetics, 
USA). Video of individual rotating, tethering cells were extracted using the software. 
Cells were tracked frame-on-frame and the times spent in different cell motions were 
recorded. Counter-clockwise (CCW) and clockwise (CW) cell rotation frequencies 
were counted using hand tally counters. Only full rotations were counted. The 
procedures were repeated twice for each cell.  
3.11. Quantitative RT-PCR 
Total RNA was extracted using TRIzol Reagent (Invitrogen, USA) and treated with 
DNaseI (Fermentas, USA) for 10 min at 37oC to remove genomic DNA. The reaction 
was stopped by heating at 98oC for 10 min. Five μg of total RNA was converted to 
cDNA using the SuperscriptTM
 
First-Strand Synthesis System for RT-PCR (Invitrogen, 
USA). Primers for quantitative real-time RT-PCR were designed with Primer Express 
software (Applied Biosystems, USA) and performed using the SYBR Green PCR 
Master Mix (Applied Biosystems, USA). The quantitative real-time RT-PCR reaction 
mix (50 μl) contained 2.5 μl cDNA (20 ng/μl), 1.5 μl (10 mM) of forward and reverse 
primers, 25 μl SYBR Green PCR Master Mix and 19.5 μl sterile H
2
0. The flagellar 
master-regulatory genes and their corresponding primers used for the expression 




Table 3-4. List of primers for quantitative real-time RT-PCR 
Primers  Forward (5’-3’)  Reverse (5’-3’) Amplicon size 
FleQ TGGAAGACAT CGCCCTGCT CGGCAGAGCG ACATGATTG 102 
FleS GAACCCTTCT TCACCACCAA GA CGAGAGCGCA ACTGCAATT 100 
FleR ACTATATCCA CCAGCAATCG CC AACCTTTCTC GTGGCCGAA 110 
FliA TCACGAAGTT GCTGCCGAA TGTCTTCCGG CAATCCATGT 130 
FlgM CGCCCAGAAC ATGCAGAAA ATAGGTGCCA TCGGCGATC 102 
RpoN TTTCCTCGAC TACGGCGAAG A TGTATTTCTG CGTGGTGACC C 109 
 
3.12. Biofilm assays 
3.12.1. Biofilm development assays 
Overnight cultures were diluted to O.D.600=0.1 and microscope coverslips (size 1, 
Heinz, Germany) were placed in the cultures for incubation. Cells were incubated for 
1 or 3 h at 30°C with shaking at 200 rpm, for development of P. putida biofilms on the 
microscope coverslips. For P. aeruginosa, the temperature for incubation was 37°C. 
After incubation, microscope coverslips were removed from cell cultures and placed 
in 0.1% w/v crystal violet for 10 s. Slides were then placed in water for 5 s to rinse off 
excess stain and air-dried. Biofilms attached to the microscope coverslips will thus be 
stained with crystal violet. 
3.12.2. Image analyses 
Biofilms formed at the air-liquid interphase of the microscope slides were imaged 
using a Deltavision wide-field microscope (Applied Precision, USA) in the 
Mechanobiology Institute (Singapore). Image analyses were carried out using Image-
Pro Plus 6.3 (Media Cybernetics, USA) where areas of biofilm coverage were 
computed. Images of biofilms from two slides from three independent clones were 
used for computation. 
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Chapter 4. Interspecies comparisons of 
swimming motility in Pseudomonas spp. and its 





4. Interspecies comparisons of swimming motility in 
Pseudomonas spp. and its control by MorA 
4.1. Background and objectives 
Flagellum-based swimming motility is a key bacterial property that allows the cell to 
move toward favourable environments.  Swimming motility has been well established 
in the peritrichous enteric bacteria E. coli model, where the control of swimming 
speeds and direction through the flagellar motor function has been described 
(Wadhams and Armitage, 2004; Macnab, 1984). However, less is known in 
monotrichous bacteria, which is likely to be different from peritrichous bacteria 
(Mitchell, 2002). In this Chapter, we describe the flagellar motor function of 
monotrichous P. aeruginosa for the first time. Comparisons with the known E. coli 
model will be made, where key differences will discussed. 
C-di-GMP signalling has been recently recognized as a new layer of control for 
swimming motility (Wolfe and Visick, 2008). We have previously described the role 
of the sensor regulator MorA in controlling the number and timing of flagella 
development in P. putida. In that report, the role of MorA in the regulation of P. 
aeruginosa motility was not addressed in detail (Choy et al., 2004). Here, we address 
the role of MorA in the regulation of motility for P. aeruginosa. Specifically, the 
effect of MorA on flagellar motor function is described. 
Throughout this thesis, P. putida wild-type and markerless ΔmorA strains are referred 
to as WT and ΔmorA, while the respective P. aeruginosa strains are referred to as 
WT-Pa and ΔmorA-Pa. 
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4.2. Swimming speeds of mono-flagellated and multi-flagellated 
Pseudomonas spp. 
4.2.1. MorA-Pa negatively regulates swimming motility 
To elucidate whether MorA in P. aeruginosa (MorA-Pa) had an effect on swimming 
motility, motility plate assays were performed. Lower motility agar concentrations 
were used for P. aeruginosa than for P. putida so as to detect differences in motility. 
Markerless ΔmorA-Pa had a significant and detectable increase in motility as 
compared to wild-type (WT-Pa, 11%), unlike previously reported, where no change in 
motility was observed (Choy et al., 2004). This motility was restored when a multi-
copy plasmid of MorA was complemented in the strain (Fig. 4-1A). In the P. putida 
strain, markerless ΔmorA also had significantly increased motility as compared to 
wild-type (70%, Fig. 4-1B), which was comparable to the transposon mutant that was 
previously reported (Choy et al., 2004). These phenotypes were restored by 
complementation (Fig. 4-1B). It is interesting that the effect on motility for mono-
flagellated ΔmorA-Pa is less than that for multi-flagellated ΔmorA in P. putida as 
compared to their respective wild-type strains. Notably, some of the complemented 
strains have lower motility than WT-Pa or WT, likely because a multicopy plasmid 
expressing MorA-Pa/MorA was used for complementation. Thus, both deletion and 
complementation strains of MorA-Pa/MorA suggest that MorA-Pa/MorA negatively 







   
Fig. 4-1 MorA-Pa affects motility in P. aeruginosa. A- P. aeruginosa PAO1 
swimming motility. Motility is increased by 11% in the morA deletion strain (ΔmorA-
Pa) as compared to wild-type (WT-Pa). The phenotypes were restored by 
complementation, through the expression of MorA in a pUP19 vector (pUPMR) in 
both WT-Pa pUPMR and ΔmorA-Pa pUPMR strains. B- P. putida PNL-MK25 
swimming motility. Motility is increased by 70% in the morA deletion strain (ΔmorA) 
as compared to wild-type (WT). The phenotypes were restored by complementation, 
through the expression of MorA in a pGB1 vector (pMorA) in both WT pMorA and 
ΔmorA pMorA strains. Asterisk * indicate that the values compared are significantly 
different. Significance was calculated using Tukey’s pairwise comparison of means, 
p=0.05. (Values are means ± SD of swim-zone diameters measured from 3 replicates 
from 3 clones for each strain. The experiment was repeated twice.) C – P. aeruginosa 
swimming zones on a motility agar plates. A larger swimming zone diameter is 
observed for ΔmorA-Pa compared to WT-Pa. D – P. swimming zones on a motility 










































4.2.2. Live tracking of swimming speeds in Pseudomonas cells 
To describe in detail the effect of MorA-Pa/MorA in swimming motility, we tracked 
speeds of individual bacteria cells. Videos of swimming planktonic wild-type P. 
aeruginosa (WT-Pa) and P. putida (WT) cells at the early exponential phase were first 
analyzed.  In P. aeruginosa WT-Pa cells, trajectories were long and straight (Fig. 4-
2A). In some cases, “run” and “reverse” motions (reversals) were also tracked, where 
turn angles were usually large (135o ≤ ϴ ≤ 180o). Of all trajectories tracked which 
recorded turns, 66% had large turn angles (Fig. 4-2C). The average speed of WT-Pa 
cells at the early growth phase was 7.7 µm/s (Fig. 4-3).  
In contrast, P. putida WT cells moved in short distances, often having trajectories that 
overlap each other, with only a small proportion of cells moving in long and straight 
trajectories (Fig 4.2B). The bacteria cells travelled at an average speed of 2.9µm/s (Fig. 
4-4B). The possibility that these cells did not swim smoothly due to drag force from 
the chamber surfaces was eliminated as the cells movements were also observed using 
deep chambers of about ~1mm height. Notably, some of the cells also exhibited a “run” 
and “reverse” motion (Fig 4-2B, panels 3-4), but because of the overlapping 








Fig. 4-2. Bacterial trajectories of swimming cells. A- P. aeruginosa WT-Pa. Cells 
swam in smooth, straight lines. Cells that “run” and “reverse” were also observed, and 
turn angles were large (135o ≤ ϴ ≤ 180o). Panels 1-4 show close-up views of cell 
trajectories turning at an angle. B- P. putida WT. Cells swam in short random 
trajectories that overlapped one another. Panels 1-4 show close-up views of cell 
trajectories moving in short random distances, note that panels 3 and 4 have “run” and 
“reverse” trajectories. (Trajectories were total cells tracked from 0-20s from one 
representative video. Timescale is indicated at the bottom right. Note that speed is a 
factor of both trajectory length and colour change.) C - P. aeruginosa WT-Pa turn 
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4.2.3. Loss of morA-Pa increases bacterial swimming speeds 
Having established the swimming patterns of wild-type Pseudomonas cells, the effect 
of MorA loss was next studied. Single-cell analyses of swimming motility had 
allowed the direct tracking of swimming speeds in a stage-specific manner. While it 
had been shown that MorA affected the motility phenotype of P. putida throughout 
the early, middle and late exponential growth phases (Choy et al., 2004), the effect of 
MorA-Pa on P. aeruginosa has not been studied. Bacterial speeds of P. aeruginosa 
cells from the three growth phases were first analyzed in order to ascertain the best 
growth stage to study the effect of MorA-Pa on P. aeruginosa motility (Fig 4-3) .  
The effect of MorA-Pa on motility was observed at both the early and middle 
exponential growth phase, where at the early growth phase, we observed a 25% 
increase in swimming speeds for ΔmorA-Pa compared to WT-Pa (9.5µm/s vs 7.6 µm/s, 
Fig. 4-3). As the growth phase increased, the effect of MorA on swimming speeds 
decreased. At the middle exponential growth phase, ΔmorA-Pa strains had a 21% 
increase in swimming speed when compared to WT-Pa (8.6 µm/s vs 7.1 µm/s, Fig. 4-
3), and the value decreased to 12% at the late exponential growth phase (7.6 µm/s vs 
6.8 µm/s, Fig. 4-3). Since there was a larger effect of MorA on swimming motility at 





Fig. 4-3. The effect of MorA-Pa on swimming motility is observed at the early 
growth phase. Motility is increased by 25% in ΔmorA-Pa as compared to wild-type 
(WT-Pa) at the early exponential growth phase as compared to 21% and 12% for the 
middle and late exponential growth phase, respectively. Asterisk * indicate that the 
values are significantly different from each other, calculated using Tukey’s pairwise 
comparison of means, p=0.05. (Values are means ± SEM, of 300 bacterial speeds 
tracked from 2 videos each from 3 clones for each strain. The experiment was 
repeated twice and the above shows data from one representative set.) 
 
Next, we studied and compared the effect of MorA/MorA-Pa on swimming motility in 
detail, at the early exponential growth phase. Similar to the trend for motility plate 
assays, swimming speeds for ΔmorA-Pa was increased compared to WT-Pa (25%, Fig. 
4-4A), and the case was similar for ΔmorA compared to WT in P. putida (2-fold, Fig. 
4-4B).  Complementation strains were also able to restore the phenotype (Fig. 4.4). 
Analysis of bacterial trajectories showed that the loss of MorA (ΔmorA-Pa) in P. 
aeruginosa strains resulted in longer trajectories over the same time periods (Fig. 4-
5C). Apart from trajectory length, ΔmorA-Pa had swimming patterns similar to that of 
WT-Pa, with straight trajectories or cells that “ran” and “reversed" with large turn 
angles. However, the number of trajectories that captured turns were reduced in 

































































reversals (n=25 vs n=46). Expectedly, the stronger effect of MorA on swimming 
motility was observed in the trajectories for P. putida. ΔmorA cells which swam 
quickly, no longer had short trajectories that overlapped. Instead, trajectories were 
long and straight (Fig. 4-5D). Interestingly, swimming patterns were now similar to P. 




Fig. 4-4. MorA is a negative regulator of swimming speeds in Pseudomonas spp. 
A- P. aeruginosa swimming speeds. Motility is increased by 25% in ΔmorA-Pa as 
compared to wild-type (WT-Pa). B- P. putida swimming speeds. Motility is increased 
by 2-fold in ΔmorA as compared to wild-type (WT). The phenotypes were restored in 
both strains by complementation using pGB1 plasmids expressing MorA (pMorA). 
Note that swimming speeds for P. aeruginosa are about 4-fold higher than P. putida. 
Asterisk * indicate that the values are significantly different from each other, 
calculated using Tukey’s pairwise comparison of means, p=0.05. (Values are means ± 
SEM, of 300 bacterial speeds tracked from 2 videos each from 3 clones for each 
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Fig. 4-5. Effect of MorA-Pa and MorA on bacteria trajectories. A- P. aeruginosa 
WT-Pa. Cells swam in smooth, straight lines. Cells that “run” and “reverse” with 
large turn angles (135o ≤ ϴ ≤ 180 o) were also observed. B- ΔmorA-Pa. Loss of 
MorA-Pa resulted in longer trajectories, swimming patterns, in general, did not 
change. C - P. putida WT. Cells swam in short random trajectories that overlapped 
one another. D – ΔmorA. Loss of MorA resulted in long and smooth trajectories in 
contrast to WT. Cells that “ran” and “reversed” with large turn angles (135o ≤ ϴ ≤ 
180 o) were also observed. Swimming patterns are now similar to P. aeruginosa. E - 
P. aeruginosa turn angles. Distribution of WT-Pa and ΔmorA-Pa cells based on 
their turn angles tracked (n =69 and 47, respectively, from 6 videos each). 
(Trajectories were total cells tracked from 0-20 s from one representative video. 
Timescale is indicated at the bottom right. Note that speed is a factor of both 
trajectory length and colour change.) Videos of these profiles are available in the 
 
4.3. The flagellar motor function in P. aeruginosa is affected by MorA 
In our previous report, increased motility observed in ΔmorA was due to 
hyperflagellation of P. putida cells across all growth phases (Choy et al., 2004). 
Therefore, the observation of increased swimming speeds was a direct effect of 
increased flagella number. This raises the question on how MorA-Pa affects the 
motility of mono-flagellated P. aeruginosa? Changes in bacterial speeds, the number 
of reversals, and turn angles by MorA in P. aeruginosa cells strongly suggested that 
the motor function was likely to be affected. We thus hypothesized that the effect of 
MorA-Pa on swimming motility was through the flagellar motor function. To study 
this property, we first sought to establish the flagellar motor function for P. 
aeruginosa through cell tethering assays. This would also be the first direct study on 
the motor function of P. aeruginosa. 
4.3.1. Characterization of rotating, tethered P. aeruginosa cells 
Videos of rotating tethered P. aeruginosa (WT-Pa) cells were analyzed. Here, we 
describe the motor function in terms of four characteristics (Fig. 4-6). Cell bodies 
rotated primarily in two directions, either CCW, or CW. Additionally, cells also 
paused in between rotations, or switched quickly in large angles (90 o≤ ϴ ≤ 180o). 
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Interestingly, unlike peritrichous E. coli, where cells spend only a small fraction (6%) 
of their time in CW rotations (Togashi et al., 1997), P. aeruginosa cells spend 
comparable times rotating in CW (32.8%, Fig. 4-7) and CCW (52.9%, Fig. 4-7) 
directions. This is expected since CW rotations for E. coli equate to a “tumble” in 
swimming patterns whereas for P. aeruginosa, CW rotations equate to a “reverse” in 






Fig. 4-6. Tethered-cell motions.  Video frames of two cells each, captured in rotating 
CCW and CW directions, pausing (Pause) and switching (Switch). Arrows indicate 
the path that cells take. (Timeframes, T, for CCW and CW rotations = 0 -1.4s, Pause 





Fig. 4-7. Time-distribution of tethered-cell motions. Rotating tethered WT-Pa cells 
move in counter-clockwise (blue), clockwise directions (green), and pause (purple) or 
switch directions (orange).The pie chart indicates the proportion of time that cells 
spend in the different motions. (Cells were observed for 1 min, n=8). Videos 
illustrating these cell motions are available in the attached CD (Appendix V). 
 
Similar to E. coli, P. aeruginosa cells also “pause” intermittently (11.5%, Fig. 4-7) 
likely as a result of futile switching events (Eisenbach et al., 1990). The shorter 
trajectories observed in P. aeruginosa cells could account for these pausing cells (Fig. 
4-2). Also, “switching” events were observed (2.8%, Fig. 4-7), where cells twitched in 
random large angles (90 o≤ ϴ ≤ 180o) before rotating in a CCW or CW direction. 
These events, which take place quickly within 1 s could possibly be incorporated into 











4.3.2. Rotation speed and frequency of motor function is affected by MorA-Pa 
Having established the patterns of rotating- tethered P. aeruginosa cells, ΔmorA-Pa 
cells were studied next. Rotating ΔmorA-Pa cells spent less time pausing (0.1% vs 
11.5% , Fig. 4-8 and Fig 4-7), with a slight increase in CW rotation (43 vs 33% , Fig. 
4-8 and Fig 4-7) and had  similar switching times (5 vs 3%,  , Fig. 4-8 and Fig 4-7) 
when compared to WT-Pa. The results from tethered cell analyses corroborate with 
the swimming trajectories as ΔmorA cells also had fewer short trajectories (Fig. 4-5). 
The increased time spent in CW rotation is an indication of increased swimming 
motility previously observed (Fig. 4-4).   
Quantitation of rotation frequencies (Table. 4-1) showed that WT-Pa rotation speeds 
averaged at about 1.15 Hz. In comparison to E. coli, this rotational frequency is 
considerably slower (1.15 vs ~6Hz) (Macnab 1984).  Nevertheless, this slower 
frequency is likely growth-stage dependent as most studies on E. coli cells were 
performed in the late exponential stage where flagellar development is complete. In 
this case, cells were studied in the early exponential stage, where MorA-Pa affects 
motility. 
In comparison with WT-Pa, there was a distinct increase (26%) in CCW rotation 
frequency (1.45 vs 1.15 Hz, Table. 4-1) for ΔmorA-Pa, while the CW rotation 
frequency remained similar (1.48 vs 1.53 Hz, Table. 4-1). The frequency of switching 
was also increased (4.22 vs 2.50 Hz, Table. 4-1) in ΔmorA-Pa. As the switching is 
likely a futile process (Ravid and Eisenbach, 1984; Eisenbach et al., 1990), the 
increased frequency, together with reduced pausing, suggests that futile motions were 
shortened in ΔmorA-Pa. Notably, the increase in CCW rotation frequencies and the 
shortened time spent in futile motions could be the reason for the reduced number of 
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reversals (Fig 4-5E) observed in swimming trajectories. Therefore, MorA-Pa 
negatively affected swimming motility in P. aeruginosa through the control of 
flagellar motor function. Specifically, it affects the speed of flagellar rotation in the 
CCW rotation, which therefore restricts the forward motion of the cell. 
 
Fig. 4-8. Time-distribution of tethered-cell motions in ΔmorA-Pa. Rotating 
tethered cells moved in counter-clockwise (blue), clockwise directions (green), and 
paused (purple) or switched directions (orange).The pie chart indicates the proportion 
of time cells spend in the different motions. Note that cells do not pause as much 
compared to WT (Cells were observed for 1 min, n=8). 
 
Table 4-1. Frequency of cell motions in tethered cells 
Cell motion WT-Pa ΔmorA-Pa 
Counter-clockwise 1.15 ± 0.22 1.45 ± 0.11 
Clockwise 1.48 ± 0.31 1.53 ± 0.17 
Switch1 2.50 ± 1.27 4.22 ± 1.15 
1Note that this refers to the switching frequency of cells that twitched in random large 










4.4. Control of bacterial motility by MorA 
4.4.1. Post-transcriptional control of bacterial motility by MorA-Pa 
A possible mode of control for swimming motility is the transcriptional control of 
flagellar pathway genes (Dasgupta et al., 2003). While the structure and number of 
flagella were previously shown to be unaffected by MorA-Pa (Choy et al., 2004), 
other flagellar development genes could play a role in regulating the motility 
phenotype observed. Therefore, the expression of flagellar master regulatory genes 
was studied in ΔmorA-Pa at the early exponential growth phase to ascertain whether 
the control of the flagellar motor function was transcriptional.  
The expression of flagellar master regulatory genes however, did not show significant 
increases in ΔmorA-Pa as compared to WT-Pa (Fig. 4-9). Hence, flagellar 
development was likely unaffected by MorA-Pa. The control of swimming motility by 
MorA-Pa through the flagellar motor likely takes place post-transcriptionally.  
Fig. 4-8. Expression of flagellar master regulatory genes. Transcriptional control of 
flagellar development was unaffected by MorA-Pa in the early growth stage 
(O.D.600nm =0.1- 0.3). Increase in gene expression was not more than 1.5 times. 
(Values are RT-PCR results from three replicates of three clones for each strain. 


























Interspecies comparisons showed that P. putida swimming speeds were nearly 2.5 
times lower than P. aeruginosa wild-type strains (Fig. 4-4A). This lower motility of P. 
putida suggests either that flagella of the multi-flagellated P. putida do not move in a 
coordinated way, thus resulting in slower swimming speeds, or that the natural habitat 
of P. putida do not require high swimming speeds. In contrast, the mono-flagellated 
pathogenic P. aeruginosa is able to swim at higher speeds. It is likely that this ability 
to move quickly allows the bacteria to swim towards favourable host environments for 
attachment and infection. Given the “investment” of cellular resources into forming 
the motility apparatus, the human pathogen P. aeruginosa seems to have a more 
efficient system than its related rhizobacterial P. putida species. 
The flagellar motor function for mono-flagellated P. aeruginosa was established for 
the first time in this study, and findings on tethered-cell movements corroborate with 
swimming trajectories and previous reports of a “run” and “reverse” strategy observed 
in monotrichous Pseudomonas citronellis (Taylor and Koshland Jr, 1974). In contrast 
to peritrichous bacteria (Togashi et al., 1997), we show that cells spend significant 
time periods in CW rotations. CCW rotation and pausing cell motions that were 
observed in E. coli, were similarly observed in P. aeruginosa. While CCW rotations 
allow cells to move forward, pausing has been established to be an intrinsic feature of 
the flagellar motor, where it was linked to the classical response to chemotactic 
stimuli. In the presence of stimuli, flagellar reversals and the occurrence of pausing 
was reduced (Eisenbach et al., 1990). It was therefore suggested that pausing is a 
result of futile switching events. In this study, a new observation of “switching” was 
observed, often within a very short timeframe and before the cell makes a decision to 
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rotate CCW or CW. These indicate that “switching” may also be a result of futile 
switching events as described earlier. 
In the process of our work, it was reported that in monotrichous Vibrio alginolyticus, 
cells also “run” and “reverse”, but upon resuming forward swimming, the flagellum 
flicks to select a new direction. In that study, the time difference between a forward 
and backward motion is uncorrelated in a chemically homogeneous medium, but the 
values become correlated in the presence of chemoattractants. It was likely that V. 
alginolyticus exploit the time-reversal symmetry of forward and backward swimming 
by using the time difference to regulate their chemotactic behaviour (Xie et al., 2011). 
These findings, therefore, corroborated well with our results, where both “pausing” 
and “switching” observed in tethered cells corresponded to the time differences in 
between a forward and backward swimming path. It is also possible that “switching” 
resulted in the flagellum “flick” mentioned. Notably, “flicking” angles for V. 
alginolyticus occurred often at 90o, but for the case of P. aeruginosa, reversals took 
place mainly between 135o ≤ ϴ ≤ 180o, and the other turn angles were distributed 
between 0 o < ϴ ≤ 135o. Additionally, the “run-reverse-flick” swimming pattern was 
not observed in our trajectories. The exact mechanisms leading to these differences 
will therefore need further experimentation. Table 4-2 provides a summary of the 
tethered cell motions observed in P. aeruginosa and their likely corresponding 




Table 4-2. Tethered cell motions and their corresponding response in free-
swimming cells 
 E. coli P. aeruginosa 
Flagellar arrangement Peritrichous Monotrichous 
Tethered cell movement CCW 3CCW 
Corresponding 
movement 
1Forward run 4Forward run 




Tethered cell movement Pause 3Switch/Pause 
Corresponding 
movement 
2Futile switching events 5Time-reversals, 
exploited for chemotaxis 
1 Macnab 1984 
2 Eisenbach et al., 1990 
3 This study 
4 Taylor and Koshland Jr 1974 
5Xie et al., 2011 
 
Previously, motility was shown to be increased in small colony variants in MorA 
knock-out cells for PA14 (Meissner et al., 2007) but this was not observed in PAO1 
(Choy et al., 2004). Meissner et al., claimed that such a difference was due to the 
strains of choice, but using more suitable assay methods, the motility phenotype for 
MorA-Pa has been established in our study for a first time in PAO1. Having 
developed upon earlier findings on MorA-Pa motility in P. aeruginosa that the effect 
was likely in the early growth phase, the study of single-cell bacterial speeds allowed 
a clear distinction of the motility phenotype. Furthermore, the control of flagellar 
motor function by MorA-Pa was elucidated through the use of tethered cell analyses. 
It is interesting that the loss of MorA increased CCW but not CW rotational 
frequencies. This suggests that the negative regulation of motility restrict cells from 
swimming ahead through forward “runs”. Having control over specific cell 
movements would therefore allow the cells to perform chemotaxis more specifically, 
either to increase forward or backward swimming motions. Additionally, the reduced 
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pausing also indicates that cells are committed to be more motile, reducing the 
occurrence of attachment, an initial stage for biofilm formation. Therefore, it is likely 
that MorA played a critical role in regulating flagellum-based swimming motility and 
also attachment. 
The reduction of pauses and increased CCW rotations were also observed in E. coli 
when chemoattractants were used, suggesting that these behaviours were linked 
(Eisenbach et al., 1990). Chemotaxis also resulted in a reduction in time-reversals of 
forward and backward swimming in monotrichous V. alginolyticus (Xie et al., 2011), 
which was likely the reasons for “pauses” and “switches” observed in P. aeruginosa. 
These findings therefore suggest that chemotaxis could affect the role of MorA in the 
regulation of swimming motility and attachment. The role of the sensory PAS domain 
could possibly play a role in such chemotactic sensing, which we address in Chapter 6 
of the Thesis. 
The control of flagellar motor function was found to be affected by MorA-Pa at the 
post-transcriptional level (Fig. 4-10A). This finding, therefore, raises the question on 
how MorA affects the motor and its switch mechanism. It is likely that such a control 
involve c-di-GMP signalling in MorA. Previous reports for E. coli and C. crescentus 
showed that the control for the flagellar motor function acts via c-di-GMP-binding 
PilZ signalling receptors, YcgR and DgrA, respectively (Paul et al., 2010; Boehm et 
al., 2010; Christen et al., 2007).  C-di-GMP, which binds to these receptors, affects 
their interaction with the flagellar motor proteins, FliG/FliM and FliF, respectively. 
Fine-tuning of c-di-GMP levels through the synergistic action of c-di-GMP signalling 
enzymes had been shown to affect flagellar motor function and bacterial speeds 
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(Boehm et al., 2010). However, studies of how a single enzyme fine-tunes c-di-GMP 
levels and in turn, its phenotypes, had not been shown.  
 A 




Fig. 4-10. MorA affects motility in Pseudomonas spp. through different pathways. 
A- Post-transcriptional control of motility by MorA-Pa. MorA-Pa regulated 
flagellar motor function, specifically CCW rotation, post-transcriptionally. Regulation 
of the flagellar motor might be through a downstream c-di-GMP binding receptor as 
previously shown for E. coli and C. crescentus. B- Control of motility by MorA at 
the level of transcription. MorA regulated the timing and number of flagellated cells. 
Increased flagellin transcription was also detected. C-di-GMP signalling in MorA 
likely allowed the regulation of two separated motility pathways. The role of the 





Notably, we show here that MorA controlled the motility phenotype in P. putida (Fig. 
4-10B) and P. aeruginosa (Fig. 4-10A) through different pathways. In P. putida, 
increased flagellin levels and hyperflagellation were observed in morAPp knockout 
cells (Choy et al., 2004). In contrast, the control for P. aeruginosa was shown to be at 
the level of post-transcription in this study (Fig 4-10A). As described in Chapter 2.2.3 
(Literature review), c-di-GMP signalling regulates flagellum-based motility at both 
transcriptional and post-transcriptional levels. Thus, while signalling mechanisms may 
be similar in MorA for both Pseudomonas spp., the motility pathway was 
differentially affected, at the level of transcriptional control in P. putida, and at the 
post-transcriptional level for P. aeruginosa. 
In the following Chapter, we elucidate the catalytic activity of the GGDEF-EAL 
bidomain MorA, and the catalytic mechanism of how MorA catalytic activity leads 
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5.  Recruitment of phosphodiesterase catalytic residues for the 
diguanylate cyclase activity of rMorA 
5.1. Background and objectives 
The role of the homologous MorA in the regulation of swimming motility through 
different pathways for P. aeruginosa and P. putida had strongly suggested that the 
control of these pathways was performed through c-di-GMP signalling, especially 
since MorA contains both the GGDEF and EAL domains. Having described the 
different properties that GGDEF-EAL bidomain proteins possess in Chapter 2.1.4, it 
would be important to determine the catalytic activity of MorA. 
In this Chapter, through recombinant protein expression, we describe the enzymatic 
properties of rMorA for the first time. The roles of the GGDEF and EAL domains in 
MorA catalytic activity and regulation are elucidated through studying the activities of 
proteins carrying point mutations in the respective motifs. Here, novel inter-domain 
interactions of the GGDEF-EAL bidomain proteins are described for the first time. 
5.2. Characterization of rMorA and rMorA-Pa 
5.2.1. Protein expression of catalytic fragments of rMorA and rMorA-Pa 
Previous attempts in creating rMorA constructs revealed that obtaining full-length 
soluble protein fractions was difficult, costly, and required resolubilization (Lye 2006). 
Therefore, we first created different fragments containing the catalytic domains of 
MorA for expression.  
Various rMorA fragments (Fig. 5-1A) from P. putida were cloned into a modified 
pET32 vector. C-terminus His6-tagged proteins were expressed in E. coli BL21 cells – 
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two fragments containing the PAS-PAC, GGDEF and EAL domains K429-D1282, 
and I438-D1282 (with a difference of 9 amino acids), had low solubility and remained 
mainly in the insoluble pellet. One fragment encoding just the GGDEF and EAL 
domain (R836-D1282), on the other hand, had good solubility and was present in the 
soluble fraction after cell lysis. The protein also gave good yield after affinity 
purification using Ni-NTA columns (Fig. 5-1B). This protein was thus used for 
downstream enzymatic analyses and was named recombinant MorA (rMorA). A 
similar fragment (R967-D1407) was generated from P. aeruginosa and named rMorA-
Pa.  
Throughout this thesis, rMorA will be used for the recombinant MorA protein from P. 





5.2.2. Properties of rMorA and rMorA-Pa 
Having successfully obtained soluble protein fractions of rMorA, we performed buffer 
optimizations using the buffer conditions described in Table 3-3 (Chapter 3.4.2). 
Proteins dialysed in the buffers were electrophoresed to ascertain their solubility. 
After dialysis, soluble protein fractions were electrophoresed to determine the purity 
and solubility in the respective buffers (Fig. 5-2A). From the gel image, pure proteins 
were obtained in all of the buffers except for buffer 5 (25mM Tris-HCl), where there 
A 





Fig. 5-1. Cloning and expression of rMorA fragments. A- Domain architectures of 
rMorA fragments. 1 - MorA full-length shows the domain architecture of MorA with 
its transmembrane, sensory PAS/PAC and catalytic GGDEF and EAL domains.  2 - 
rMorA proteins containing PAS/PAC, GGDEF and EAL domains were generated. 3- 
rMorA containing its catalytic domain gave good solubility; this protein was used for 
downstream analyses and subsequent cloning. Brackets indicate residues with 
reference to the full length protein. B- Protein solubility of recombinant proteins. 
Left panel - insoluble (IS) and soluble (S) fractions of protein containing PAS-PAC 
and catalytic domains for the fragments K429-D1282 and I438-D1282. Right panel - 
soluble fraction and its purified fraction of rMorA containing just the catalytic 
domains, R836-D1282 of rMorA from P. putida, and R967-D1407 of rMorA-Pa from 
P. aeruginosa  
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was no soluble protein. The rMorA protein was most soluble in buffers 2 and 8,   
containing 150mM NaCl, 75mM NaH2PO4, pH 7.5, and 150 mM NaCl, 75 mM Tris-
HCl, pH 7.5, respectively (Fig. 5-2A, top panel). Buffer 8 was chosen for use in future 
experiments as it was a more common buffer for DGC and PDE assays. Using this 
buffer condition, 7.5 ml of 20 µM protein can be purified from 1 L of bacterial culture. 
Next, the solubility of rMorA-Pa in buffer 8 was tested. In comparison to rMorA, 
rMorA-Pa was less soluble in buffer 8 after dialysis (Fig. 5-2A, bottom panel) and 
only 5 ml of 15 µM protein was purified from 1 L of bacterial culture. Due to the 
lower solubility of rMorA-Pa, most of the detailed protein characterization and 
enzymatic studies were performed using rMorA.  
Secondary structure characterization from the protein sequence of rMorA showed that 
rMorA consisted of about 52% α-helices and 28% extended and β-strands (Fig. 5-2B). 
This was confirmed by our circular-dichroism spectra of rMorA where its secondary 























 Vector                                   MHH HHHHSSGLVPRGS  
                                          CCH HHHHHHHHHHHHH 
836  RKASEQR IHRLAYYDAL THLPNRTLFQ DRLHTALQAA ERQKSWVVLMFLD 
     HHHHHHH HHHHCCECCC CCCECHHHHH HHHHHHHHHH HHCCCCEEEEEEE 
886  LDHFKPI NDSLGHAAGD RMLKDMATRL LACVDDDDTV ARMGGDEFTLLLQ 
     ECCHHHH HHHHCHHHHH HHHHHHHHHH HHCCCCCCEE EEECCCEEEEEEC 
936  HRSNREL ALNRAIHVAE QILASLVRPF VLEGREFFVT ASIGIALSPQDGN 
     CCCCHHH CHHHHHHHHH HHHHHHHCCE EECCCEEECC EEEEEEECCCCCC 
986  ELSQLMK NADTAMYHAK ERGKNNFQFY QADMNASALE RLELESDLLRHAL 
     CHHHHHH HHHHHHHHHH HCCCCEEEEC CCCCHHHHHH HHHHHHHHHHHHH 
1036 EQNEFVL YYQPQFSGDG KRLTGAEALL RWRHPRRGLV PPGDFIPVLEELG 
     HCCCEEE EEEEEEECCC CCEEEEEEEE EEECCCCCEE CHHHHHHHHHHCC 
1086 LVVDVGD WVISEACRQL KTWHQQRVRV PKVSVNISAR QFSDGQLGTRIAT 
     HHHHHHH HHHHHHHHHH HHHHHCCCCC CEEEEECCHH HHCCCCHHHHHHH 
1136 ILRETGL PPACLELELT ESILMREVSE AMQILAGLKN LGLSIAVDDFGTG 
     HHHHHCC CHHHEEEEEE HHHHHHCHHH HHHHHHHHHH CCCEEEEEEECCC 
1186 YSSLNYL KQFPIDVLKI DRTFVDGLPS GEQDAQIARA IIAMAHSLNLAVI 
     CECHHHH HHCCCCEEEE CHHHHCCCCC CHHHHHHHHH HHHHHHHCCCEEE 
1236 AEGVETH EQLDFLREHG CDEVQGYLFG RPMPAGRFEA QFCNDALFMFD 
     EECCCCH HHHHHHHHCC CCEECCCCCC CCECHHHHHH HHHHHCCCCCC 
    
     
 
C  
Fig. 5-2. Properties of rMorA. A- Solubility of rMorA and rMorA-Pa. Top panel: 
Equal concentrations of rMorA were dialyzed in buffers 1-8 and the soluble fraction 
was electrophoresed. Buffer 8 was most ideal for downstream analyses at low salt 
concentration with sufficient yield. Bottom panel: rMorA and rMorA-Pa dialysed in 
buffer 8, rMorA is the more soluble protein. (Equal concentrations of proteins were 
dialysed prior to gel electrophoresis.) B and C- Secondary structure of rMorA as 
determined by sequence analyses (B) and CD (C).  rMorA consisted mainly of α-
helices. 
H = helix : H (alpha helix) + G (3-10 helix) + I (pi-helix) classes 
E = strand : E (extended strand) + B (beta-bridge) classes 
C = others : T (turn) + S (bend) + . (the rest) 
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Next, we investigated the oligomeric state of rMorA. Dimerization is required for 
DGC activity, while PDEs, on the other hand, generally functioned as monomers 
(Schirmer and Jenal, 2009). Size-exclusion chromatography of rMorA showed that it 
formed both monomers and dimers in vitro (Fig. 5-3A). Monomers and dimers 
extracted from SEC were able to form new dimers and monomers, respectively, when 
they were passed through the SEC column a second time (Fig. 5-3B). This indicates 
that an equilibrium of monomers and dimers exists. The elution profile of rMorA was 
compared to PleD since it is a DGC that dimerizes and is similar in size (50kDa) to 
rMorA (Chan et al., 2004). The ability of rMorA to exist as both monomers and 
dimers suggest that it can function as a PDE or DGC in vitro.  
A B 
  
Fig. 5-3. An equilibrium exists between monomers and dimers of rMorA. A- 
rMorA exists as both monomers and dimers. Elution profile of rMorA SEC, 
monomers (14.5ml) and dimers (7.8ml) for rMorA correspond to those of PleD. B – 
rMorA monomers form new dimers and vice versa. Monomers and dimers from A 


































5.2.3. Annotation of rMorA and rMorA-Pa suggest their bifunctionality 
Sequence comparisons of rMorA and rMorA-Pa were carried out to ascertain the 
likely function of the protein. There are two main canonical sequences that GGDEF 
domains are associated with. Firstly, the catalytic A-site with an intact GG[D/E]EF 
motif, and secondly, the allosteric c-di-GMP-binding RXXD I-site (Seshasayee et al., 
2010). We show here that both morA and morA-Pa gene sequences each contain the 
conserved GGDEF motif (Fig. 5-4A). In comparison with other GGDEF-EAL 
bidomain proteins, DGC-1, with a known DGC activity (Tal et al., 1998), retained the 
GGDEF motif sequence whereas inactive DGCs CC3396 and FimX have altered 
GEDEF and GDSIF motif sequences (Christen et al., 2005; Kazmierczak et al., 2006). 
This data thus suggest that the GGDEF domain of MorA/MorA-Pa is likely active. 
The allosteric c-di-GMP-binding RXXD I-site, known to be 5 residues upstream of the 
GGDEF motif (Christen et al., 2006; De et al., 2008), however, is absent in 
MorA/MorA-Pa. In contrast to PleD and WspR, morA encoded a DXXD motif while 
morA-Pa encoded a SXXD motif, suggesting that MorA/MorA-Pa does not exhibit 
product inhibition through c-di-GMP binding at the I-site (Fig. 5-4A).  The in silico 
model of the I-site is shown in Appendix III. 
The catalytic EAL domain, on the other hand, is considered intact if it contains the 
canonical EAL motif and the conserved DDFGTGYS motif (Schmidt et al., 2005), 
which was later described to be part of the β6-loop required for substrate binding and 
catalysis (Rao et al., 2009). Key residues required for Mg2+ and c-di-GMP interaction 
(Fig. 5-4B) have also been previously identified in a biochemical study (Rao et al., 
2008). Both morA and morA-Pa gene sequences encoded the EAL motif, DDFGTGYS 
motif/β6-loop, as well as key residues for Mg2+ and c-di-GMP interactions, indicating 
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that MorA/MorA-Pa can be an active PDE. In contrast, the GGDEF-EAL bidomain 
protein DGC1, did not encode a complete DDFGTGYS motif/β6-loop. Sequence 
analyses of morA/morA-Pa thus strongly suggest that it is likely a bifunctional 
GGDEF-EAL bidomain protein. 
 
A GGDEF domain 
MorA   [Pseudomonas putida]     AGDRMLKDMATRLLAC-VDDDDTVARMGGDEFTLLLQHRSNRELALNRAIHVAEQILASL 958 
MorA-Pa [Pseudomonas aeruginosa] AGDRMLQEVATRLSAC-VSQDDTVARMGGDEFTLLLPSQGDREIALKRAIQVAELILGRL 1089 
DGC1  [Gluconacetobacter xylinus]AGDVVLKVISNRLLAL-VHPEDAVCRLGGDEFALILNHTL-----HKYPLSLMLEKLLAE 249 
PleD   [Caulobacter crescentus] IGDEVLREFALRLASN-VRAIDLPCRYGGEEFVVIMPDTA---LADALRIAERIRMHVSG 397  
WspR   [Pseudomonas aeruginosa] EGDEALRKVAATIREASSRPSDLPARYGGEEFALVLPNTS---PGGARLVAEKLRMAVAA 277 
ScrC   [Vibrio parahaemolyticus] VGDEILKLSAQRLQNV-ARKTDLLARIGGDEFLLVIPDLP----DNDTAKRVASSVLSAF 384 
CC3396 [Caulobacter crescentus] RADLVLAALGSRLAAA-FPAQSILGRIGEDEFAVLCQPLG---------YEPSDVLRSAL 221  
FimX   [Pseudomonas aeruginosa] GIDLLLGQLAGLMREQ-FGEEADLARFGDSIFAALFKGKT-----PEQAQAALQRLLKKV 373  
                                              RXXD I-Site    
B EAL domain                   
MorA   [P putida]     VLYYQPQFSGD-GKRLTGAEALLRWRHPRRGLVPPGDFIPVLEELGLVVDVGDWVISEACRQLKTWHQQRV 1109 
MorA-Pa[P aeruginosa] VLHYQPQFTGD-GRRLTGAEALLRWQHPRRGLVPPSEFIPVLEEIGLVAQVGDWLLAEACKQLRSWHKAKV 1240 
RocR   [P aeruginosa] EAYYQPKVALD-GGGLIGAEVLARWNHPHLGVLPPSHFLYVMETYNLVDKLFWQLFSQGLATRRKLAQLGQ 226 
FimX   [P aeruginosa] RLLFQPVISLRG-DSHENYEVLLRLLNPQGQEVPPAEFLHAAKEAGLAEKIDRWVILNSIKLLAEHRAKG- 524 
CC3396 [C crescentus] TPYFQPIVRLS-TGALSGFEALARWIHPRRGMLPPDEFLPLIEEMGLMSELGAHMMHAAAQQLSTWRAAHP 374 
YahA[Escherichia coli]KPWIQPVFCAQ-TGVLTGCEVLVRWEHPQTGIIPPDQFIPLAESSGLIVIMTRQLMKQTADILMPVKHLLP 192 
LapD   [P fluorescens ELYFQPVVAAQDTQVVLHYKVLSRLLDEHGQTIPAGRFLPWLERFGWTARLDRLMLEQVLRQMAGHEES—495 
YcgF   [E coli]       SPTINDHFAFH-----PIVDPLSRRIIAFEAIVQKNEDSPSAIAVGQRKDGEIYTADLKSKALAFTMAHAL 232 
DGC1   [G xylinus]    ELYYQPIMNFS-TGRCDQIEALVRWHHPQRGLLAAESFRDVFLDAALAQVMSPRLVKSFQNDMRMWNTSLD 400 
                                                               
              
MorA   RVP--KVSVNISARQFSD-GQLGTRIATILRETGLPPACLELELTESILMRE-VSEAMQILAGLKNLGLSIAVDDFGTGYSSLNYL 1191 
MorA-PaRVP--KVSVNLSARQFAD-GQLGERIAAILYETGIPPACLELELTESILMSD-VAEAMQILSGLKRLGLAIAVDDFGTGYSSLNYL 1322 
RocR   PIN---LAFNVHPSQLGS-RALAENISALLTEFHLPPSSVMFEITETGLISA-PASSLENLVRLRIMGCGLAMDDFGAGYSSLDRL 307 
FimX   --HQTKLFVHLSSASLQD-PGLLPWLGVALKAARLPPESLVFQISEADATSYLKQ-AKQLTQGLATLHCQAAISQFGCSLNPFNAL 608 
CC3396 AMGNLTVSVNLSTGEIDR-PGLVADVAETLRVNRLPRGALKLEVTESDIMRD-PERAAVILKTLRDAGAGLALDDFGTGFSSLSYL 458 
YahA   DNF--HIGINVSAGCFLA-AGFEKECLNLVNKLGNDKIKLVLELTERNPIPV-TPEARAIFDSLHQHNITFALDDFGTGYATYRYL 274 
LapD   ------LALNLSSATLAD-PQALNKIFEILRAHSNLGSRLTLEIGEEQLPEQ--AVLEQLTRRLRELGFSLSLQRFGGRFSMIGNL 572 
YcgF   ELGDKMISINLLPMTLVNEPDAVSFLLNEIKANALVPEQIIVEFTESEVISR-FDEFAEAIKSLKAAGISVAIDHFGAGFAGLLLL 317 
DGC1   TYP--NLTINLSRLDLLN-IGFQNDLEAEIKRQGGKASDYVLEVSESVLAGRRSDRVLQRLQDSKELGFQLTLDDFGLATLPISVL 483 
                                                                                 >    
                                                                                                               Β6-loop 
                                                                                    
MorA          KQFPIDVLKIDRTFVDGLPSGEQDAQIARAIIAMAHSLNLAVIAEGVETHEQLDFLREHGCDEVQGYL 1259 
MorA-Pa     KQFPIDVLKIDRSFVDGLPHGEQDAQIARAIIAMAHSLNLMVIAEGVESQAQLDFLREHGCDEVQGYL 1390 
RocR          CEFPFSQIKLDRTFVQKMKTQPRSCAVISSVVALAQALGISLVVEGVESDEQRVRLIELGCSIAQGYL 375 
FimX     KHLTVQFIKIDGSFVQDLNQVENQ-EILKGLIAELHEQQKLSIVPFVESASVLATLWQAGATYIQGYY 674 
CC3396        TRLPFDTLKIDRYFVRTMGNNAGSAKIVRSVVKLGQDLDLEVVAEGVENAEMAHALQSLGCDYGQGFG 526 
YahA          QAFPVDFIKIDKSFVQMASVDEISGHIVDNIVELARKPGLSIVAEGVETQEQADLMIGKGVHFLQGYL 342 
LapD          SRLGLAYLKIDGSYIRAIDQESDKRLFIEAIQRAAHSIDLPLIAERVETEGELAVIREMGLFGVQGQL 591 
YcgF          SRFQPDRIKISQELITNVHKSGPRQAIIQAIIKCCTSLEIQVSAMGVATPEEWMWLESAGIEMFQGDL 385 
DGC1          RTISFTQAKISRGLVKDIETSQQACDVVAHLIGLAHAFGLSVTVSGVETKAQMDALREMGADRIQGFY 551 
                                                               
 
 
Fig. 5-4. The sequence of rMorA and rMorA-Pa suggests that it contains active 
DGC and PDE domains. A – MorA possibly encodes a functional GGDEF 
domain. The morA gene encodes the GG[D/E]EF motif required for DGC activity 
(boxed), but not the allosteric, c-di-GMP-binding  RXXD inhibitory (I) site. B – 
MorA possibly encodes a functional EAL domain. The morA gene also encodes the 
catalytic EAL motif (boxed), as well as the conserved β6-loop and key residues 
required for Mg2+ () and c-di-GMP () interaction.  Annotation adapted from 













5.3. The catalytic function of rMorA 
5.3.1. rMorA and rMorA-Pa is a dominant DGC and weak PDE in vitro 
Enzymatic assays were performed to determine the catalytic functions of rMorA. 
After incubation of rMorA with the DGC substrate, GTP, c-di-GMP was produced 
(Fig. 5-5A). On the other hand, incubation of rMorA with the PDE substrate, c-di-
GMP, produced pGpG (Fig. 5-5E). The reaction products were confirmed by HPLC 
(Fig. 5-5A and Fig. 5-5E) and MS (Fig. 5-5B and Fig. 5-5F).  For the DGC reaction, a 
strong and clean c-di-GMP peak was detected at 20.5 min in the HPLC profile of the 
reaction product (Fig. 5-5A), which was later verified by MS as c-di-GMP (m/z=688.8, 
Fig 5-5B).  For the PDE reaction, a small but detectable peak was observable in the 
HPLC profile of the reaction product (Fig. 5-5E), and the identity was verified by MS 
as pGpG (m/z=707.2, Fig 5-5F). These findings indicated that rMorA is a bifunctional 
enzyme with both DGC and PDE activities. The enzymatic activity of rMorA-Pa was 
also tested, and it has a similar catalytic function as rMorA, with DGC and PDE 
reaction products of c-di-GMP  (Fig. 5-5D) and pGpG (Fig. 5-5H), respectively. The 
DGC and PDE assays were carried out using PleD (Fig. 5-5C) and CC3396 (Fig. 5-5G) 
as their respective enzyme controls. 
Further elucidation of enzyme activity showed that rMorA is a dominant DGC with a 
specific activity of 49.0 c-di-GMP produced/µM protein/min. PDE activity, however, 
was weak, with a specific activity of 4.8 c-di-GMP consumed/µM protein/min (Table 
5-1). The specific DGC activity of rMorA is, therefore, 18-fold higher than its PDE 
activity. In comparison with the reaction controls, rMorA also exhibits 2.4-fold higher 
DGC specific activity when compared to PleD, and 6.5-fold lower PDE specific 
activity when compared to CC3396. 
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Given that the sequences of the catalytic domains for rMorA and rMorA-Pa were 82% 
similar (Appendix IV) and that both protein sequences contained the key residues 
required for DGC and PDE activity, it was likely that the catalytic activities are 
similar. As expected, results showed that rMorA-Pa also had a dominant DGC 
(48.8nM c-di-GMP produced/µM protein/min, Table 5-1) and weak PDE activity 
(3.5nM c-di-GMP consumed/µM protein/min, Table 5-1). These activities were 
minimally different from rMorA (± 1 nM c-di-GMP /µM protein/min), indicating that 
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Fig. 5-5. rMorA is a bifunctional enzyme with both DGC and PDE activities. A- 
rMorA DGC activity. rMorA produced c-di-GMP (20.5 min) after incubation with 
200 µM GTP (5.0 min). B- MS of DGC product. MS profile of the DGC product from 
the HPLC peak eluate at 20.5 min corresponded to c-di-GMP  m/z = 688.8. C- PleD 
DGC activity. HPLC of reaction products from the DGC control reaction using PleD 
also showed that c-di-GMP was produced (peak at 20.5 min). D- rMorA-Pa DGC 
activity. rMorA-Pa also produced c-di-GMP (20.5 min) after incubation with 200 µM 
GTP (5.0 min). E- rMorA PDE activity. rMorA produced pGpG (8.5 min) after 
incubation with 50 µM c-di-GMP (20.5 min). F- MS of PDE product. MS profile of 
the PDE product from the HPLC peak eluate at 8.5 min corresponded to pGpG m/z = 
707.2. G- CC3396 PDE activity. HPLC of reaction products from the PDE control 
CC3396 also showed that pGpG was produced (peak at 8.5 min).H- rMorA-Pa PDE 
activity. rMorA-Pa also produced pGpG (8.5 min) after incubation with 50 µM c-di-
GMP (20.5 min).  
 
 
Table 5-1. Specific activities for DGC and PDE activities of rMorA.  
1Values given are means ± SD of triplicate measurements. 
2N.D., not detected  
  







No cofactor, rMorA 2N.D N.D 
10mM ZnCl2, rMorA N.D N.D 
10mM MgCl2,rMorA 49  ± 4.2 4.8 ± 1.9 
10mM MgCl2,10mM KCl,  54  ± 5.0 N.D 
10mM CaCl2, rMorA N.D N.D 
10mM KCl, rMorA 1.4 ± 0.1 N.D 
With acetyl phosphate 
10mM MgCl2, rMorA 48 ± 5.3 0.51 ±0.20 
Control proteins (with 10mm MgCl2) 
PleD (DGC control) 22 ± 1.1 N.D 
CC3396 (PDE control) N.D 19 ± 2.1 
rMorA-Pa 49  ± 5.8 3.5 ± 1.7 
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5.3.2. Co-factor analyses reveal that rMorA activity is Mg2+-dependent 
Previous reports have shown that DGC and PDE activities are dependent on their co-
factors, and different co-factors can inhibit or activate their enzyme activity (Rao et al., 
2008;Tamayo 2005). Co-factor analyses were, therefore, performed for rMorA DGC 
and PDE activities, where the protein was tested for activity in the presence of 
different co-factors. From our findings, we show that rMorA is dependent on Mg2+ for 
both DGC and PDE activity (Table 5-1). A time-series was also obtained for rMorA 
DGC activity and c-di-GMP was not formed in the absence of Mg2+ (Fig. 5-6).  
 
Fig. 5-6. rMorA DGC reaction is Mg2+-dependant. In the absence of Mg2+, c-di-
GMP formation was not observed when GTP was incubated with rMorA. In contrast, 
with Mg2+, c-di-GMP formed readily and accumulated over time. (Values given are 
means ± SD of triplicate measurements). 
 
 
5.3.3. Phosphorylation of rMorA does not affect DGC activity 
Activation of DGC activity by phosphorylation has been shown in previous reports 
(Paul et al., 2007). Incubation of rMorA with the phospho-donor, acetyl phosphate, 
however, did not show any change in DGC activity when compared to rMorA (48.0 
nM c-di-GMP produced /µM protein/ min vs 49.0 nM c-di-GMP produced/µM 
protein/ min Table 5-1). This thus indicates that the catalytic domains of rMorA were 






























5.3.4. Substrate binding of rMorA to GTP 
Titration data showed that rMorA was best-fitted to a one binding site model (Fig, 5-
7). The GTP-binding enthalpy of rMorA is exothermic in nature (ΔH = 347.2) and is 
associated with low binding affinity in the micromolar range (K = 4.83 E5). The 
binding data corroborates with the DGC model, where one molecule of GTP binds to 
one monomer of rMorA.  
 
 
Fig. 5-7. ITC for titration of GTP against rMorA. GTP binding for rMorA follows 
a one binding site model. The GTP-binding enthalpy of rMorA is exothermic in nature 




5.3.5. Hydrolysis GTPγS by rMorA 
We next attempted to decouple the two opposing enzymatic activities using the 
substrate analogue for DGC, GTPγS (Fig. 5-8), which is expected to be non-
hydrolyzable. Contrary to expectation, rMorA hydrolyzed GTPγS, with 97% 
efficiency when compared to GTP (152.7 vs 157.4 µM c-di-GMP produced, Fig. 5-8). 
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In comparison, the control PleD had only 26% efficiency (11.0 vs 41.7 µM c-di-GMP 
produced, Fig. 5-8). This hydrolysis was dependant on the DGC activity of rMorA, as 
a DGC mutant (E929K) did not produce c-di-GMP. These findings, taken together, 
suggest that the DGC catalytic pocket of rMorA has greater flexibility than PleD. 





Fig. 5-8. rMorA hydrolyzes GTPγS. A-rMorA hydrolyzes GTPγS at the 
same efficiency as GTP. Levels of c-di-GMP produced by rMorA hydrolysis of 
GTPγS were similar to that of GTP (97% efficiency). The DGC control, PleD, 
did not produce c-di-GMP from GTPγS at low substrate concentrations, and 
produced significantly less c-di-GMP at high GTPγS concentrations (26%). 
Hydrolysis of GTPγS was dependent on DGC activity as the E929K mutant did 
not convert GTPγS to c-di-GMP.  (* indicate samples that were significantly 
different from each other, p< 0.05. Values given are means ± SD of triplicate 
measurements.).  B - HPLC profiles of reaction products. DGC reaction of 
protein incubated with 600µM GTPγS for rMorA (left panel) and PleD (right 
panel). rMorA converts GTPγS to yield a distinct c-di-GMP peak (20.5 min) as 






























































5.4. Inter-domain effects of the PDE domain on rMorA DGC activity 
5.4.1. Site-directed mutations do not alter protein properties 
To investigate whether DGC and PDE activities of rMorA were associated with their 
respective motifs, we generated site-directed mutations in their conserved residues, 
namely, E929K and F930L of the GGDEF motif, and, E1058K and L1060G of the 
EAL motif.  These residues were selected for mutagenesis as site-directed-mutations 
in the catalytic motifs, except for D928 and A1059 of GGDEF and EAL, respectively, 
have previously been shown to affect their respective activities (Güvener and 
Harwood, 2007; Kirillina et al., 2004). From the mutant proteins generated, only 
F930L was insoluble. Hence, E929K, E1058K and L1060G were used for further 
experimentation. 
Next, we tested whether the mutations affected purity, yield, protein fold, or 
dimerization of the recombinant proteins carrying amino acid replacements.  The size, 
purity and yield were not affected by the mutations as observed in gel images of the 
proteins. Single and clear, protein bands of ~47kDa were observed and they had 
similar concentrations to rMorA (Fig. 5-9A). CD spectroscopy of the mutant proteins 
showed that they had similar profiles to rMorA, indicating that protein fold and 
secondary structure were also not affected by the mutations (Fig. 5-9B).  
Similar to rMorA, an equilibrium existed between monomers and dimers of the mutant 
proteins (Fig. 5-9C-D).  The mutant proteins formed monomers and dimers in vitro 
(Fig. 5-9C). When these monomer and dimer eluates were passed through the SEC 
column a second time, they were also able to form new dimers and monomers, 
respectively (Fig. 5-9D). Hence, the amino acid substitutions did not affect the 










































































Fig. 5-9. Site-directed mutation do not affect protein properties of rMorA. A-
Size, purity and yield. SDS-PAGE profile show that size, purity and yield of 
mutants were similar to MorA. B – Protein secondary structure. Protein fold as 
determined by CD spectroscopy is not affected by the amino acid substitutions. C-
D – An equilibrium also exists between monomers and dimers of rMorA 
mutants. SEC shows that rMorA mutants form monomers and dimers in vitro (C). 
Monomers are able to form new dimers (D). 
 








5.4.2. E1058 and L1060 are required for DGC activity 
DGC and PDE assays were next carried out with rMorA carrying the amino acid 
substitutions. As expected, mutations in the conserved GGDEF and EAL motifs led to 
complete loss of their corresponding activities (Table 5-2). The E929K protein, 
carrying a mutation in the GGDEF motif, did not produce c-di-GMP when incubated 
with the DGC substrate, GTP, indicating that DGC activity was completely lost. The 
proteins carrying mutations in the EAL motif, E1058K and L1060G, also did not 
produce pGpG when incubated with the PDE substrate, c-di-GMP. Thus, PDE activity 
was also lost in these proteins. 
Interestingly, DGC activities of the two PDE mutants were significantly lower than 
wild-type rMorA. E1058K and L1060G had 6-fold and 3-fold reductions in specific 
activity of DGC, respectively (Table 5-2). E1058K, which had the lowest DGC 
activity, is implicated in Mg2+ binding for PDE activity (Rao et al., 2009). These 
results suggest that a functional PDE domain is necessary for DGC activity. Due to the 
fundamental significance of this result, further experiments were carried out to 
investigate the inter-domain effects of the PDE domain on DGC activity. We 
performed DGC reactions over time (Fig. 5-10A) and determined enzyme velocities 
over different substrate concentration (Fig. 5-10B). The kinetic parameters (Kcat, Km, 
Kcat/Km) calculated from Fig. 5-9B were reflected in Table 5-2. E1058K and L1060G 
had 11-fold and 7-fold reductions in Kcat (Table 5-2), and Km remained constant for 
E1058K. Interestingly, L1060G had a 2-fold decrease in Km (this will be addressed in 
the next section). The inter-domain effect on PDE activity was observed for all GTP 

























































Table 5-2.  Enzyme activities of rMorA and its GGDEF and EAL mutants. 





Fig. 5-10. Inter-domain effects – mutations in PDE domain affect rMorA DGC 
activity. A – DGC activity over time. Both the rate and final quantities of c-di-GMP 
production is reduced by PDE mutations. B – Vo vs substrate concentration curve. 
Vo is constitutively reduced in PDE mutants for all GTP concentrations tested. Km is 
reduced in L1060G. Note the slight reduction of rMorA Vo values compared to the 
best-fit curve above 300 µM GTP substrate concentrations. (Values given are means 




Protein DGC PDE 



















rMorA 49 ± 4.2 0.0038  0.12  0.032  4.8 ± 1.9 
E929K N .D -  -  -  N.D 
E1058K 8.9 ± 0.60  0.00033  0.11  0.0030  N.D 
L1060G 18 ± 0.40  0.00053  0.061  0.011  N.D 
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5.4.3.  L1060 of the PDE domain is a novel c-di-GMP-specific DGC inhibitory 
site 
The DGC activity of rMorA was lower at GTP substrate concentrations above 300µM 
compared to lower GTP concentrations (Fig. 5-10B). This provided a hint that the 
activity could be regulated by product inhibition. The Km for L1060G was nearly half 
of that for rMorA, indicating that L1060 of the PDE domain could be a critical part of 
the inhibitory site for DGC activity. Inhibition assays by c-di-GMP were, therefore, 
performed to test for this. With pre-incubations of increasing c-di-GMP concentrations, 
the DGC activity of both rMorA and the PDE mutant, E1058K, were reduced in a 
dose-dependent manner (Fig. 5-11A). Such inhibition by c-di-GMP was removed in 
L1060G, showing that L1060 is an important residue for c-di-GMP product inhibition of 
DGC activity.  
Next, we investigated whether the inhibition could be due to the PDE product, pGpG. 
Inhibition assays using pGpG did not reduce DGC activity, confirming that the DGC 
product inhibition occurs via c-di-GMP (Fig. 5-11B). A dose-response plot was then 
obtained to understand the response of this inhibition (Fig. 5-11C). A sigmoidal dose-
response plot was obtained, and the IC50 of inhibition is achieved at 35µM. As in the 
case of P. putida, rMorA-Pa of P. aeruginosa also showed such c-di-GMP-specific 
product inhibition (Fig. 5-11D).  
Since c-di-GMP binding to the I-site increases dimer and tetramer formation leading 
to DGC inhibition (De et al., 2008;Chan et al., 2004), we next sought to understand if 
the inhibition reported here also affects dimerization levels.  Native gel analyses, 
however, revealed that dimerization was not affected by c-di-GMP levels (Fig. 5-11E). 



























































































































































































Fig. 5-11. L1060 of the PDE domain is a novel c-di-GMP-specific DGC inhibitory 
site. A - C-di-GMP product inhibits DGC activity at L1060. Levels of c-di-GMP 
produced decrease with increasing c-di-GMP inhibitory concentrations for rMorA and 
E1058K but not L1060G. B - Product inhibition is independent of PDE activity. 
Levels of c-di-GMP produced with pGpG pre-incubations. C - Dose-response curve 
of c-di-GMP produced with increasing inhibitory concentrations of c-di-GMP. 
DGC activity decreased in rMorA but not for L1060G. The IC50 value was 35µM. (A-
C, values given are means ± SD of triplicate measurements). D – rMorA-Pa also 
exhibits product inhibition. Product inhibition by c-di-GMP is also observed in 
rMorA-Pa. Not that levels of c-di-GMP produced under inhibitory conditions are 
similar to rMorA. E - Dimerization of rMorA was not affected by c-di-GMP 
binding. Native gel analysis of 10µM proteins with and without 50µM c-di-GMP 
showed that rMorA formed dimers under both conditions (arrow). The mutations also 




For DGC activity, we have reported initial velocities of up to 100nm c-di-GMP 
produced/µmol protein/min (Fig. 5-10B) which was comparable to PleD in an earlier 
report (200 nm c-di-GMP produced/µmol protein/min) (Christen et al., 2006). As the 
analysis method in the earlier report was different, we resolved this by testing the 
protein under our conditions. The activity of rMorA DGC was still comparable to 
PleD, and the DGC activity of MorA was 2.4-fold higher (Table 5-2). The DGC 
activity of MmoS was also within the same logarithmic range, being 6-fold higher 
than rMorA (Ukaegbu et al., 2006). Notably, AxDGC2, which has a similar PAS-
GGDEF-EAL domain architecture to MorA, also had a highly comparable Km value at 
112 compared to rMorA (Km=116) (Qi et al., 2009). Our findings were therefore 
comparable with the activities of DGCs previously reported, especially when 
compared to enzymes of similar architecture.  
Dimerization assays of rMorA also showed that an equilibrium between monomers 
and dimers existed, suggesting transient dimerization of rMorA allowed for the DGC 
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activity observed. This was similar to tDGC (Rao et al., 2009), which synthesized c-
di-GMP efficiently through transient dimerization. 
Modelling of the DGC pocket based on PleD structure (PDB ID: 2V0N) revealed a 
conserved role for E929 in Mg2+-dependent GTP catalysis via polar contacts (Fig. 5-
12A). The residue E929 was required for a chain of interactions involving Mg2+ and 
D928 which, in turn, allows GTP to bind to the catalytic pocket. Replacement of the 
acidic side chain of E929 with a basic lysine residue likely disrupted GTP interaction 
with the catalytic pocket. Hence, this explains the loss of DGC activity by E929 
mutation.  
For PDE activity, rMorA exhibits a weak yet measurable activity - specific activity for 
MorA PDE is 18-fold lower than its opposing DGC activity, and 6.5-fold lower that 
the PDE control, CC3396. Notably, it is also lower than most PDEs previously 
reported. The PDE activity is only detected under high enzyme concentrations over a 
long incubation period. Therefore, it is likely that in other reported bidomain proteins 
with only one major function reported, the other activity could similarly be present at 
very low levels. The model of the PDE domain based on tdEAL structure (PDB ID: 
3n3t) revealed that the E1058 site was crucial for interaction with Mg2+ that in turn 
interacts with c-di-GMP substrate. Similar to the case of E929K, replacement of the 
acidic side chain of E1058 with a basic lysine residue likely disrupted c-di-GMP 
interaction with the catalytic pocket.  L1060, on the other hand, contributes to the c-di-
GMP binding pocket. Replacement of the hydrophobic L1060 side-chain with glycine 
would thus likely alter the c-di-GMP binding ability. Hence, the E1058K and L1060G 
mutations possibly affected c-di-GMP substrate binding to the PDE catalytic pocket, 
which therefore explains the loss of PDE activity in both proteins. The interactions of 
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both residues described here are similar to previous reports (Minasov et al., 2009; Rao 
et al., 2009). 
There were three different categories of GGDEF-EAL bidomain proteins previously 
described (Chapter 2.1.4). The first category includes bidomain proteins that have 
only one activity, whereas bifunctional proteins that may require specific triggers for 
activation describe the second category. MorA, on the other hand, likely falls in the 
third category, where bidomain proteins exhibit inter-domain interactions. Like 
CC3396 and RbdA, where the full-length protein with both PDE and DGC domains is 
required for optimal PDE activity (Christen et al., 2005; An et al., 2010), the reverse 
is true for MorA. There is a constitutive requirement of the PDE domain for DGC 
activity in MorA. We show here that this PDE requirement involves E1058 and L1060 of 
the canonical EAL motif. The PDE domain plays a more dominant role via its effect 
on DGC activity than through hydrolysis of c-di-GMP. The PDE domain contributes 
up to 83% of DGC activity, whereas it removes only 6% of c-di-GMP produced by 
DGC activity. If such interdependence is also widely present in other bidomain 
signalling enzymes, it could explain the selective advantage in retaining both domains 
widely across microbial genomes.  
In the bifunctional MtbDGC, a cysteine mutation in the PDE domain removed both 
DGC and PDE activities, suggesting that similar inter-domain interactions could be 
present (Gupta et al., 2010). Combined with our observations it is likely that GGDEF-
EAL bidomain proteins could have evolved such that the DGC activities have become 
inter-dependant on their opposing PDE domains, and vice versa, possibly due to the 
need for regulation of c-di-GMP levels in cells. Other examples of protein domains 
that have evolved from enzymatic to regulatory functions also exist. For example, the 
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ROK (repressor, ORF, kinase) protein family have proteins that play a role in catalysis 
as sugar kinases and xylose repressors (Titgemeyer et al., 1994), while a family of 
amino acid binding proteins also contained a phenylalanine biosynthetic enzyme, 
PheC (Tam and Saier Jr, 1993). 
A B 
 
Fig. 5-12. Model of rMorA GGDEF and EAL domains. A - Model of GGDEFMorA 
(green) superimposed on PleD (pink, PDB ID: 2V0N). The sticks represent side-chains 
of residues interacting with Mg2+ with red dashes indicating the polar contacts. The 
GGDEFMorA model revealed that E929 was required for a chain of interactions 
involving M1 (Mg+), D928 and M2 (Mg+). M2 forms three hydrogen bonds with the 
phosphate groups (orange sticks) of GTP, thus allowing GTP to bind to the catalytic 
pocket. E929 is thus implicated in DGC activity. B - Model of EALMorA (green) 
superimposed on tdEAL (blue, PDB ID: 3n3t). The sticks represent side-chains of 
residues interacting with Mg2+ with red dashes indicating the polar contacts. The 
model of EALMorA revealed that the E1058 site was crucial for interaction with M1 
(Mg+) that in turn interacts with the phosphate groups (orange sticks) of c-di-GMP. 






We describe here the role of two residues of the EAL motif, E1058 and L1060, which are 
both present in the PDE catalytic pocket and are essential for PDE activity. Yet only 
one, namely, L1060, is involved in product inhibition of DGC activity. As described in 
the model (Fig. 5-12B), E1058 is involved in c-di-GMP-interaction and L1060 does not 
make any direct contact via bonds with c-di-GMP but forms the binding pocket. 
Hence, L1060 could be available more readily for allosteric interaction. Given the 
involvement of L1060 in both the c-di-GMP binding pocket and the low catalytic 
activity, we speculate that binding mechanisms in the substrate pocket of the PDE 
domain initiates product inhibition in its DGC domain. The allosteric product 
inhibition described here possibly represents a new class of allostery for bidomain 
signalling enzymes that do not possess the I-site. 
The catalytic mechanisms of MorA were elucidated in this chapter, and we show that 
while MorA is a dominant DGC, the PDE domain seems to have significantly lost its 
activity. The PDE domain, however, has acquired regulatory properties where inter-
domain interactions of the PDE domain acts to regulate c-di-GMP levels through 
firstly, a constitutive requirement of the PDE domain for DGC activity, and secondly, 
a c-di-GMP dose-dependent product inhibition. We next sought to find out whether 
these observations were physiologically relevant in two target pathways, motility and 








Chapter 6. Inter-domain interactions in MorA 




6. Inter-domain interactions in MorA affect biological functions  
6.1. Background and objectives 
We have described two novel inter-domain interactions of the PDE domain on DGC 
activity for GGDEF-EAL bidomain proteins in Chapter 5. In this Chapter, the 
biological significance of these inter-domain interactions will be addressed. Through 
the introduction of site-directed mutants in morA deletion strains, we investigate the 
effects of inter-domain interactions on biochemical and biological function in P. 
putida. Namely, results from two biological output pathways of motility and biofilm 
formation are reported. 
Since the catalytic activity of both rMorA and rMorA-Pa strains were similar, inter-
domain effects on biological functions observed in P. putida have been tested in P. 
aeruginosa. Due to the availability of an A352V site-directed mutant, the role of the 
first PAS domain in the regulation of biological function was elucidated in P. 
aeruginosa as well. Therefore, we corroborate in vitro findings on MorA/MorA-Pa 
catalytic activity to their effects on motility and biofilm formation. To our knowledge, 
this is the first study connecting these novel inter-domain interactions of c-di-GMP 
signalling enzymes to biological function. 
6.2. Inter-domain interactions alter MorA biochemical function 
To study whether the DGC function and its inter-domain effect had any biological 
significance, full-length MorA and its point mutants of the GGDEF (pE929K) and 
EAL (pE1058K, pL1060G) motifs were expressed in P. putida markerless ∆morA 




6.2.1. Intracellular levels of c-di-GMP are affected by MorA signalling 
Loss of MorA (∆morA) resulted in decreased intracellular c-di-GMP levels (26%, Fig. 
6-1B) when compared to wild-type, indicating that MorA likely functions as a 
dominant DGC. This was verified when the loss of DGC activity (∆morA pE929K) 
also reduced c-di-GMP levels (30%, Fig. 6-1B) when compared to its control (∆morA 
pMorA). These results showed that MorA the dominant DGC activity of MorA 
contributed to intracellular c-di-GMP levels. 
Next, the role of the PDE domain in altering intracellular c-di-GMP levels was 
addressed. We reasoned that if the catalytic activity or DGC product inhibition 
function of the PDE domain affected intracellular c-di-GMP levels, the PDE point 
mutants will behave in the opposite direction of the DGC mutant, and such strains will 
have higher intracellular c-di-GMP. On the other hand, if the PDE domain positively 
affects MorA DGC function, then, PDE and DGC mutants will produce similar 
phenotypes, and the PDE mutant strains will have lower intracellular levels. The same 
logic was used when the role of the PDE domain was explored in the control of 
motility and biofilm formation. 
Experimental data supported that inter-domain effects altered intracellular c-di-GMP 
levels. Both PDE mutants ΔmorA pE1058K and ΔmorA pL1060G had 5% and 18% 
lower intracellular c-di-GMP levels, respectively, when compared to their control 
(∆morA pMorA, Fig. 6-1B). The PDE mutant, ΔmorA pE1058K, which has the 
stronger constitutive positive effect on DGC activity, did not have a significant 
decrease in intracellular levels as compared to ΔmorA pL1060G. It is noteworthy that 
ΔmorA pE1058K is also the stronger mutant for PDE activity. Therefore, these 
opposing biochemical effects may have resulted in the slight decrease in intracellular 
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c-di-GMP for this strain. Nevertheless, the trend observed for both PDE mutants 
indicated that the PDE domain altered intracellular c-di-GMP levels through its 







Fig. 6-1. MorA contributes to intracellular levels of c-di-GMP.  A – MS profile 
and standard curve of c-di-GMP. C-di-GMP levels were quantitated in intracellular 
nucleotide extracts for different strains by Multiple Reaction Monitoring (MRM) 
analysis in ion trap MS. Strains were grown to the mid-logarathmic planktonic phase 
prior to extraction. Left- MS profile, right- linearity of daughter ions used for MRM in 
nucleotide extracts spiked with increasing levels of c-di-GMP.  B- Intracellular 
levels of c-di-GMP. Left- levels of intracellular c-di-GMP in wild-type (WT) and 
morA (ΔmorA) deletion strains of P. putida expressing full-length MorA or its mutants 
in GGDEF or EAL motifs. (Values are means ± SEM of 2 independent extractions 
from 3 clones for each strain). Right – Tukey’s pairwise comparison of means and 
















































































6.3. Inter-domain interactions alter swimming motility 
As the biochemical property of MorA altered intracellular c-di-GMP, it was likely that 
MorA affected swimming motility through c-di-GMP signalling. Swimming motility 
was therefore, studied in the DGC and PDE point mutants for both Pseudomonas 
strains. 
6.3.1. MorA mutations in GGDEF and EAL motifs lead to increased P.putida 
swimming motility 
Swimming motility was studied in P. putida using swimming motility plate assays as 
well as single-cell tracking of swimming speeds. As expected, the loss of DGC 
activity (∆morA pE929K) increased swimming motility as determined by motility agar 
plates (4-fold, Fig. 6-2A) and bacterial swimming speeds (2 -fold, Fig. 6-2B), when 
compared to the control ∆morA pMorA. Thus, ∆morA pE929K had a similar 
phenotype as the loss of MorA, indicating that MorA controls swimming motility 
through its dominant DGC activity. 
Interestingly, in the PDE point mutants, ΔmorA pE1058K and ΔmorA pL1060G, 
motility was increased as determined by swimming motility plate assays (2.8 and 2.6-
fold, Fig. 6-2A) and bacterial speeds (25% and 78%, Fig. 6-2B), similar to that of the 
DGC mutant. This shows that the PDE domain affected swimming motility through its 
constitutive positive effect on DGC function. Following the same trend as the 
enzymatic assays, ∆morA pE1058K, which has a stronger effect on DGC activity as 
compared to ∆morA pL1060G, also increased swimming speeds more significantly 








Fig. 6-2. Mutant strains in GGDEF and EAL motifs have increased swimming 
motility in P. putida.  A - Relative swim zones of strains on motility agar plates. 
Left- relative swim zones of bacterial strains. (Strain designations are described in 
Fig.6-1. Values are means ± SD of 3 measurements from 3 clones for each strain.) 
Right – Tukey’s pairwise comparison of means and their significant levels. NS, non-
significant at p=0.05.    B – Swimming speed of bacteria. Left – average bacteria 
speeds of single cells tracked. Right – Tukey’s pairwise comparison of means and 
their significant levels. NS, non-significant at p=0.05. (Values are means ± SEM of 3 























































6.3.2. Inter-domain interactions of MorA alter swimming motility in P. 
aeruginosa 
Having observed that inter-domain interactions of MorA affected swimming motility 
in P. putida, similar effects were investigated in P. aeruginosa. Full-length MorA-Pa 
and its point mutants of the GGDEF (E1060K, pUPMR G*) and EAL (E1189K, 
pUPMR E*) motifs were expressed in P. aeruginosa markerless ∆morA-Pa strains and 
studied for swimming motility. 
Similar to the findings on P. putida, loss in DGC activity (∆morA-Pa pUPMR G*) 
resulted in increased swimming motility as determined by motility agar plates (50%, 
Fig. 6-3A) and bacterial swimming speeds (23%, Fig. 6-3B), when compared to its 
control (∆morA-Pa pUPMR). This phenotype was similar to the loss of morA-Pa, 
where motility was also reduced, indicating that MorA also controls swimming 
motility through its dominant DGC activity in P. aeruginosa. 
 The effect of inter-domain interactions was also observed in the PDE point mutant, 
ΔmorA-Pa pUPMR E*. Motility was increased by 25% in swimming motility plate 
assays (Fig. 6-3A), but in swimming speed analyses, the slight increase in speed was 
not significant when compared to ∆morA-Pa pUPMR (Fig. 6-3B). Notably, this could 
be because the swimming motility phenotype of MorA-Pa in P. aeruginosa is 
inherently weaker than that of MorA in P. putida.  Nevertheless, if the PDE activity of 
MorA-Pa affected motility, then the PDE point mutant should behave in the opposite 
direction of the DGC point mutants, and have decreased swimming motility. However, 
both motility assays showed that the PDE mutant was either more motile or similar in 
speed when compared to its control, suggesting that the constitutive positive effect of 
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the PDE domain on DGC function was present in MorA-Pa, and the increased motility 





Fig. 6-3. Mutant strains in GGDEF motif have increased swimming motility in P. 
aeruginosa.  A - Relative swim zones of strains on motility agar plates. Left- 
relative swim zones of bacterial strains in wild-type (WT-Pa) and morA-Pa (ΔmorA-
Pa) deletion strains of P. aeruginosa expressing full-length MorA-Pa (pUPMR) or its 
mutants in GGDEF (pUPMR G*) or EAL (pUPMR E*) motif. (Values are means ± 
SD of 3 measurements from 3 clones for each strain.) Right – Tukey’s pairwise 
comparison of means and their significant levels. NS, non-significant at p=0.05.    B – 
Swimming speed of bacteria. Left – average bacteria speeds of single cells tracked. 
(Values are means ± SEM of 3 videos from 2 clones for each strain, n=300.) Right – 
Tukey’s pairwise comparison of means and their significant levels. NS, non-
significant at p=0.05. The GGDEF mutant has increased swimming motility for both 


















































6.3.3. MorA-Pa  affects flagellar motor function via c-di-GMP signalling 
Since MorA affected the flagellar motor function of P. aeruginosa, cell tethering 
assays were performed to ascertain the effect of GGDEF and EAL point mutants on 
the flagellar motor. As shown previously in Chapter 4.3.2., the loss of morA-Pa 
resulted in increased flagellar rotation. Complementation restored the flagellar rotation 
phenotypes (Fig. 6-4A). Expectedly, a mutation in the GGDEF domain resulted in 
increased flagellar rotation frequency (2.5-fold, Fig. 6-4A), whereas a mutation in the 
EAL domain resulted in rotation frequencies similar to that of its control ∆morA-Pa 
pUPMR. These results, therefore, confirm that the DGC function of MorA acts to 
control swimming motility via the flagellar motor. 
The CCW and CW cell motions were thus studied in the GGDEF mutant (Fig. 6-4B, 
Table 6-1). Similar to the loss of morA-Pa, there were also slight increases in time 
spent in CW rotations (37 vs 33%, Fig. 6-4B), comparable times spent in switching (5% 
vs 3%, Fig. 32B), but with reduced time spent pausing (2 vs 11%, Fig. 6-4B) when 
compared to WT-Pa. Interestingly, the loss of DGC activity also resulted in higher 
CCW rotation frequencies (1.70 vs 1.15 Hz, Table 6-1), but CW rotation speeds 
however were lower (1.27 vs 1.48 Hz, Table 6-1). Similar ∆morA-Pa, the switching 
speed was also slightly higher than WT-Pa (2.83 vs 2.50 Hz, Table 6-1). Taken 
together, these results show that ∆morA-Pa pUPMR G* altered flagellar rotation in a 
similar manner like ∆morA-Pa by increasing forward (CCW) rotation speeds and by 
shortening futile switching events and pauses. Therefore, MorA-Pa controls flagellar 
motor function through its dominant DGC activity. 
The increased CCW rotation speeds in ∆morA-Pa pUPMR G* would mean that cells 
have a forward-swim bias. This can be determined from the number of reversals the 
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swimming cells make, since such cells are likely moving in one direction within the 
tracked time. From our results, the number of turn angles tracked in swimming cells 
corroborated with the effects on motor function (Fig. 6-4C), where ∆morA-Pa pUPMR 
G* had the least number of reversals (n=15) compared to WT (n=46) or ∆morA-Pa 
(n=25), indicating that cells were swimming forward most of the time.  Notably, the 
reversals contributing to these differences had mainly large turn angles (135˚≤ ϴ ≤ 
180˚), and the number of turns with smaller turn angles (0˚< ϴ ≤ 135˚) were 
comparable for the strains (n=20-25). 
 
Table 6-1. Frequency of cell motions in tethered cells 
Representative videos of these cells are available in the attached CD (Appendix V) 
  
 WT-Pa ΔmorA-Pa 
ΔmorA-Pa pUPMR 
G* 
Counter-clockwise 1.15 ± 0.22 1.45 ± 0.11 1.70 ± 0.12 
Clockwise 1.48 ± 0.31 1.53 ± 0.17 1.27 ± 0.14 
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   WT-Pa   ∆morA-Pa ∆morA-Pa pUPMR G* 
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Fig. 6-4. Rotation frequencies and cell motion of tethered bacteria cells. A – 
Rotation frequency of tethered cells. (Strain designations are described in Fig. 6-3). 
Left - frequency of rotations (Hz) for rotating, tethered cells. (Values are means ± SD 
of 8 tethered cells for each strain.) Right – Bonferri’s pairwise comparison of means 
and their significant levels. NS, non-significant at p=0.10. B – Time-distribution of 
tethered-cell motions. Rotating tethered cells moved in counter-clockwise (blue), 
clockwise directions (green), and paused (purple) or switched directions (orange).The 
pie chart indicates the proportion of time cells spend in the different motions. (Cells 
were observed for 1 min, n=8). C- P. aeruginosa turn angles. D Distribution of WT-
Pa, ΔmorA-Pa and ΔmorA-Pa pUPMR G* cells based on their turn angles tracked (n 











































6.4. Inter-domain interactions alter biofilm formation 
6.4.1. Inter-domain interactions alter biofilm formation in a pathway- and 
developmental-stage specific manner in P. putida 
To study the effect of inter-domain interactions on biofilm formation, biofilms of P. 
putida strains carrying full-length MorA and its point mutants were grown on 
coverslips and visualized. Similar to the trend observed for swimming motility, both 
the loss of MorA (∆morA) and the loss of DGC activity (∆morA pE929K) resulted in 
decreased biofilm formation at biofilm initiation (12-fold and 23-fold, 1 h, Fig. 6-5A 
and Fig. 6-5B) and at a later stage (3 h) of biofilm development (13-fold and 42-fold, 
3 h, Fig. 6-6A and Fig. 6-6B), when compared to their respective controls. These 
phenotypes were restored in the complementation strain (∆morA pMorA). This 
indicates that MorA also controls biofilm initiation and biofilm formation at 3 h 
through its dominant DGC activity. 
PDE mutants were next analyzed to address the role of the PDE domain on biofilm 
formation. Similar to the DGC mutant, ∆morA pE1058K, which has a stronger effect 
on DGC activity, also had reduced biofilm initiation (14%, Fig. 6-5A and Fig. 6-5B), 
suggesting that the constitutive positive effect of the PDE domain DGC activity 
affected biofilm initiation. Interestingly, however, this constitutive effect was not 
observed in the other PDE mutant, ∆morA pL1060K. Instead, ∆morA pL1060K had a 
7.5-fold increase in biofilm initiation compared to its control (∆morA pMorA, Fig. 6-
5A and Fig. 6-5B). An increase in biofilm initiation could be due to the absence of 
PDE activity, or the loss of product inhibition. Involvement of PDE activity, however, 
can be eliminated since ΔmorA pE1058K, which also lost its PDE activity, behaved in 
the opposite direction. Therefore, the loss of product inhibition affected biofilm 
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initiation. It is interesting to note that the effect of product inhibition was not observed 
in motility assays, demonstrating that it functions in a pathway-specific manner. 
At the later stage of biofilm development (3 h), however, PDE mutants behaved in the 
opposite direction of the DGC mutant. Both PDE mutants formed 23-24% more 
biofilms, while the DGC mutant formed 42-fold less biofilms than ∆morA pMorA 
(Fig. 6-6A and Fig. 6-6B). Hence, PDE activity played a significant role specifically 
in the later stage of biofilm development at 3 h. 
In summary, the dominant DGC activity of MorA positively controlled P. putida 
biofilm formation at both biofilm initiation and formation. However, the role of the 
PDE domain changes with biofilm development. Firstly, the constitutive positive 
effect of the PDE domain on DGC activity was observable at biofilm initiation, where 
concurrently, DGC product inhibition takes place in the specific pathway and stage of 
biofilm initiation. At a later stage of biofilm development, however, these inter-
domain interactions were not observable as PDE activation then takes place to act in 
controlling the growth of biofilm. Therefore, the multiple roles of the PDE domain act 













    
Fig 6-5. One of the two EAL mutant strains has increased biofilm at initiation 
stage. A – Biofilm visualized at 1 h (representative images). (Strain designations 
are described in Fig. 6-1). The DGC mutant and morA deletion strain have minimal 
biofilm. Note that ΔmorA pL1060G formed 7.5-fold more biofilms than ΔmorA 
pMorA. Scale bar (on WT panel) represents 10µm. B – Quantitation of biofilm 
growth area. Left – area of biofilm growth (values are means ± SEM of four 
coverslips). Right- Tukey’s pairwise comparison of means and their significant levels 





























Fig 6-6. Both PDE mutants formed more biofilms at biofilm a later stage of 
biofilm formation. A – Biofilm visualized at 3 h (representative images). (Strain 
designations are described in Fig. 6-1). The DGC mutant and morA deletion strain also 
have minimal biofilm. Note that both ΔmorA pE1058K and ΔmorA pL1060G formed 
23-24% more biofilms than ΔmorA pMorA. Scale bar (on WT panel) represents 
10µm. B – Quantitation of biofilm growth area. Left – area of biofilm growth 
(values are means ± SEM of four coverslips). Right- Tukey’s pairwise comparison of 


























6.4.2. Inter-domain interactions of MorA alter biofilm formation in P. 
aeruginosa 
Biofilm growth was next studied in P. aeruginosa strains to ascertain whether a 
similar inter-domain effect and activation of PDE in MorA-Pa controlled biofilm 
formation. Interestingly, biofilm growth followed the trend observed in P. putida. 
Firstly, loss of morA-Pa  and the loss of DGC activity both resulted in decreased 
biofilms formed at biofilm initiation (33% and 59%, Fig,. 6-7A and Fig.6-7B) and at a 
later stage of biofilm development after 3 h (18% and 46%, Fig,. 6-7A and Fig. 6-7B), 
indicating that MorA-Pa controlled biofilm formation through its DGC activity. 
Secondly, the PDE mutant (∆morA pUPMR E*) produced 20% less biofilms at 
biofilm initiation than its control (∆morA pUPMR), although it was not significantly 
different (Fig. 6-7A and Fig. 6-7B). Therefore, similar to observations for swimming 
motility, the constitutive positive effect of the PDE domain on DGC function was 
likely present in MorA-Pa, but its effects on biofilm initiation were weaker as 
compared to those observed in P. putida.  
At the later stage of biofilm development (at 3 h), however, the PDE mutant (∆morA 
pUPMR E*) did not form more biofilms than its control (∆morA pUPMR). Instead, 17% 
less biofilms were formed (Fig. 6-8A and Fig 6-8B). This indicates that inter-domain 
interactions of the PDE domain on DGC activity still persist, and that PDE activation 
had not taken place. While it is likely that PDE activation at the later stage of biofilm 
development (3 h) is specific only to P. putida, there is also a possibility that P. 
aeruginosa biofilms had not reached the same biofilm development stage after 3 h. It 
is also possible that PDE activation takes place at a different biofilm development 
stage for P. aeruginosa. As with the case observed for the control of motility, where 
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although MorA acts to control motility in both strains, identification of the stage 
where the control takes place was key. Therefore, further experimentation of other 




Fig 6-7. Inter-domain interactions are observed at biofilm initiation. A – Biofilm 
visualized at 1 h (representative images). (Strain designations are described in Fig. 
31). The DGC mutant and morA-Pa deletion strain form less biofilms. Note that 
ΔmorA-Pa pUPMR E* produced less biofilms than ΔmorA-Pa pUPMR. Scale bar (on 
WT-Pa panel) represents 5µm. B – Quantitation of biofilm growth area. Left – area 
of biofilm growth (values are means ± SEM of four coverslips). Right- Tukey’s 
pairwise comparison of means and their significant levels for biofilms at 1 hour.  NS, 































Fig 6-8. Inter-domain interactions, but not PDE activation, are observed at a later 
stage of biofilm development. A – Biofilm visualized at 3 h (representative images). 
(Strain designations are described in Fig. 31). The DGC mutant and morA-Pa deletion 
strain also form less biofilms. Note that ΔmorA-Pa pUPMR E* produced less biofilms 
than ΔmorA-Pa pUPMR. Scale bar (on WT-Pa panel) represents 5µm. B – Quantitation 
of biofilm growth area. Left – area of biofilm growth (values are means ± SEM of four 
coverslips). Right- Tukey’s pairwise comparison of means and their significant levels 



























6.5. Role of PAS domain in MorA regulation 
Since MorA controlled motility and biofilm formation through its catalytic c-di-GMP 
signalling domains, what then is the role of its sensory PAS domains in regulating 
these signals? To ascertain this, a PAS site-directed mutant (A352V, pUPMR P*) was 
introduced into the P. aeruginosa morA-Pa deletion strain for comparisons with the 
wild-type control, ΔmorA-Pa pUPMR. PAS and GGDEF/EAL double point mutants 
were also studied for motility and biofilm formation. The above PAS mutation is 
found on the first PAS domain of MorA-Pa. 
In motility plate assays, the PAS point mutation did not affect motility as compared to 
ΔmorA-Pa pUPMR. However, a slight reduction in motility was observed when this 
mutation was introduced into ΔmorA-Pa pUPMR G* (11%, Fig. 6-9A) and ΔmorA-Pa 
pUPMR E* (8%, Fig. 6-9A). Further elucidation of the motility phenotypes were next 
carried out using the more sensitive and stage-specific single-cell tracking of bacteria 
speeds. Using this method, a significant reduction of motility was detected when the 
PAS mutation was introduced into ΔmorA-Pa pUPMR (12%, Fig. 6-9B). Similarly to 
motility plate assays, reductions were also observed when the mutation was 
introduced in ΔmorA-Pa pUPMR G* (17%, Fig. 6-9B) and, to a lesser extent, ΔmorA-
Pa pUPMR E* (6%, Fig. 6-9B). 
As a trend of decreased motility was observed in all PAS site-directed mutants 
compared to their respective controls, it is likely that the PAS domain acts to regulate 
the motility phenotype controlled by MorA. In addition, effects of the mutation were 
observed in both GGDEF and EAL site-directed mutants, indicating that this control 
by the PAS sensory domain is upstream of the c-di-GMP signals generated by MorA. 
The effect of the PAS mutation was also most distinct in the DGC mutant, which was 
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the dominant activity affected MorA motility. Therefore, it is likely that the PAS 
domain acts to regulate c-di-GMP signalling in MorA, which, in turn, affected motility. 
A B 
 
Fig. 6-9. PAS domain regulates motility phenotype controlled by MorA. A - 
Relative swim zones of strains on motility agar plates. A PAS point mutation (P*) 
in the first PAS domain of MorA-Pa was introduced into ΔmorA-Pa deletion strains 
carrying full-length MorA-Pa (pUPMR) or its mutants in the GGDEF (pUPMR G*) or 
EAL (pUPMR E*) motif. (Values are means ± SD of 3 measurements from 3 clones 
for each strain.)   B – Swimming speed of bacteria. Average bacteria speeds of single 
cells tracked. Note that strains carrying P* mutations have reduced motility compared 
to their corresponding strains. (Values are means ± SEM of 3 videos from 2 clones for 
each strain, n=300.) Asterisk * indicate that the values compared are significantly 
different. Significance was calculated using Tukey’s pairwise comparison of means, 
p=0.05. 
 
The role of the PAS domain in the control of biofilm formation was next determined. 
Biofilms at 1 h were visualized and quantitated, and results showed that the PAS 
mutant increased biofilm initiation by 56% as compared to ΔmorA-Pa pUPMR (Fig. 6-
10A and Fig. 6-10B). When this mutation was introduced in GGDEF and EAL site 



























































respectively (Fig. 6-10A and Fig. 6-10B). At the later stage of biofilm development, 
only the GGDEF mutant had a significant increase in biofilms formed (ΔmorA-Pa 
pUPMR P*G*, 80%, Fig. 6-11A and Fig. 6-11B), although the trend of increased 
biofilms were still observed to a slight extent for the other strains (ΔmorA-Pa pUPMR 
P*, 7%, and ΔmorA-Pa pUPMR P*E*, 8%,  Fig. 6-11A and Fig. 6-11B). 
 Similar to observations in the control of motility, it is likely that the PAS domain acts 
to regulate the biofilm formation phenotype controlled by MorA. The effects of the 
mutation were observed in both GGDEF and EAL site-directed mutants. However, 
these effects were stronger for GGDEF at the later stage of biofilm development. This 
indicates that the control of the biofilm phenotype by the PAS sensory domain is 
through MorA c-di-GMP signalling. It is also possible that the control of biofilm 
formation by the PAS domain takes place only at biofilm initiation. This would, 
therefore, explain why at a later stage of biofilm development, we do not observe an 
effect of the PAS mutation on most strains. Only the GGDEF mutant, which has not 
formed much biofilm, was affected by the PAS mutation. 
The role of the first PAS domain of four such domains of MorA has been elucidated in 
this study. Taking findings on motility and biofilm formation, it is likely that the PAS 
domain acts to negatively control MorA c-di-GMP signalling, and, in turn, the 
phenotypes MorA controls. What is the role of the other PAS domains? There is a 
possibility that while the first domain acts to negatively control MorA c-di-GMP 
signalling, the others may function as sensory domains that activate it through 
dimerization. More experimentation will, therefore, be needed to understand the role 







Fig. 6-10. PAS domain regulates biofilm initiation by MorA. A - Biofilm 
visualized at 1 h (representative images). (Strain designations are described in Fig. 
9). The PAS mutant strains form more biofims. Scale bar (on ΔmorA-Pa pUPMR 
panel) represents 5µm. B – Quantitation of biofilm growth area. Left – area of 
biofilm growth (values are means ± SEM of four coverslips). Asterisk * indicate that 
the values compared are significantly different. Significance was calculated using 
































Fig. 6-11. PAS domain regulates biofilm formation by MorA. A - Biofilm 
visualized at 3 h (representative images). (Strain designations are described in Fig. 
9). The PAS mutant strains form more biofims. Scale bar (on ΔmorA-Pa pUPMR 
panel) represents 5µm.  B – Quantitation of biofilm growth area. Left – area of 
biofilm growth (values are means ± SEM of four coverslips). Asterisk * indicate that 
the values compared are significantly different. Significance was calculated using 































The dominance of DGC activity of MorA under in vitro conditions (Chapter 5) is 
corroborated by in vivo results in this chapter. Firstly, measurable changes in 
intracellular c-di-GMP levels, indicate that in vivo MorA DGC activity alter overall 
cellular c-di-GMP levels. The biological effects of a strong DGC activity that increase 
c-di-GMP levels and lead to reduced motility and increased biofilm formation seen 
here were consistent with other reports (Jenal and Malone, 2006).  
MorA, which belongs to the category of GGDEF-EAL bidomain proteins with inter-
domain interactions, exhibits a constitutive requirement of the PDE domain for DGC 
activity in both motility and biofilm formation for P. putida. There seems to be a fine-
tuned control of c-di-GMP by inter-domain interactions whereby small changes in the 
signalling molecule can lead to large effects in motility and different stages of biofilm 
development. While DGC activity and its inter-domain interactions affect swimming 
motility and biofilm initiation more strongly that PDE activity, the latter played a 
significant role at a later stage of biofilm development. For the case of P. aeruginosa, 
the constitutive requirement of the PDE domain for DGC activity is observed in 
motility and biofilm formation, indicating that the biochemical mechanisms of altering 
c-di-GMP levels are similar in both strains. Interestingly, however, PDE activation 
was not observed at the later stage of biofilm development. Further experimentation 
would therefore be needed to establish this.  
Intriguingly, this is the first report of PDE activation at the later stage of biofilm 
development. As PDE activity often play a role in biofilm dispersal (Barraud et al., 
2009; An et al., 2010), it is possible that this onset of PDE activity by MorA at the 
later stage of biofilm development act to trigger the stage of biofilm dispersal.  The 
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duration of this PDE activation observed at the later stage of biofilm development is 
not known, therefore, PDE activation at biofilm dispersal should be studied.  
As shown in an earlier study, MorA affects P. putida motility through c-di-GMP 
signalling at levels of transcription but the pathway for P. aeruginosa remained 
unknown. In this report, we show that this control of motility via c-di-GMP signalling 
affected flagellar motor function. Specifically, DGC activity affected the forward 
swimming property of P. aeruginosa. This is the first report of a DGC affecting the 
CCW bias of swimming motility speed in P. aeruginosa. Previously, the action of 
PDEs has been shown to affect flagellar motor function in E. coli, where the absence 
of PDEs increased c-di-GMP-binding to the receptor YcgR that in turn, binds the 
flagellar motor and reduces rotation speeds (Boehm et al., 2010, Fig 6-12A). 
Interestingly, we observe that the absence of MorA, on the other hand, increased 
rotation speeds. It is possible that the control of MorA occurred through similar c-di-
GMP effectors (Fig 6-12B). A YcgR homologue has not been found in P. aeruginosa 
(Unpublished). Notably, the motor stators for P. aeruginosa are likely different from E. 
coli, which suggests that the c-di-GMP effector binding the stator could also be 
different. Therefore, elucidation of the specific interaction between downstream c-di-






Fig. 6-13. Role of c-di-GMP signalling in the control of flagellar motor function.  
A – PDE activity increases flagella rotation speeds. PDEs like YhjH reduce levels 
of c-di-GMP that in turn, reduces the binding of c-di-GMP to YcgR. Unbound YcgR 
does not inhibit flagellar motor function. B – DGC activity of MorA decreases 
flagellar rotation speeds. The DGC activity of MorA affects flagellar motor function 
likely through an unknown c-di-GMP effector. 
 
Of all c-di-GMP signalling proteins, about 23% are associated with the PAS domain 
(Chapter 2, Section 2.1, Table 2-1). PAS domains are known to be sensors of light 
intensity, oxygen concentration and redox potential, to name a few (Taylor and Zhulin, 
1999). In c-di-GMP signalling, PAS domains are often incorporated to regulate DGC 
and PDE activities. For example, the binding of gaseous oxygen (Tanaka et al., 2007), 
and changes in redox  (Qi et al., 2009) or light  (An et al., 2010)  can be perceived by 
PAS domains that, in turn, regulate DGC or PDE activities. For the case of MorA-Pa, 
we show that the first PAS domain acts to regulate its catalytic activity, and more 
significantly, its dominant DGC activity. Notably, some of these effects did not 
significantly alter c-di-GMP signalling. One likely explanation is that the PAS 
mutation we obtained was at a weakly-conserved site (Fig. 6-13). Thus, further studies 
on specific conserved residues may allow a better understanding of the role the PAS 
domain in altering these phenotypes. 
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In addition, the environmental signal specific to this PAS domain, together with the 
role of the two other PAS domains on MorA-Pa, remain to be elucidated. It is 
noteworthy that of all bidomain GGDEF-EAL proteins, 46% are associated with these 
sensory PAS domains, possibly due to the increased need of regulation between the 
catalytic functions.  
 
In this Chapter, we show that the effects of MorA/MorA-Pa on swimming motility 
described in detail in Chapter 4 were directly affected by the DGC activity. Our in 
vitro enzymology findings on MorA catalytic activity and inter-domain interactions 
(Chapter 5) were also corroborated with biological function - the inter-domain effects 
of the PDE domain on DGC activity affect motility and biofilm formation in P. putida, 
and to a lesser extent, P. aeruginosa. In addition, the role of the first MorA-Pa PAS 
domain in regulating these c-di-GMP signals was elucidated for the first time.  
The findings for this Thesis are summarized in the next Chapter, where we propose a 
model of how MorA activity regulates c-di-GMP levels, and in turn, biological 
function. 
  
MorA [P aeruginosa] -RQAATALAAIDERVLVTRADGRLSYLNPQAERLFGISS----AQARQHHLLGLLPDLEP  346 
MmoS2[M capsulatus] –ARLKQAMDANSEMILLTDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETL  267 
FixL [A brasilense] MLRFQAMLDTVPDGVVIIDAEGRIQTFNPACERLFGWTAAEVIGHNVKMLMPPPYREEHD  72 
RbdA [P aeruginosa] –ERAQITLASIGDGVITADTQGGISYLNPAAEQMTNWTLDKARGLPLASLFRIVDESSRE  303 
NtrB     ---SAVATDTSGVTYWSSARMGWSAAMGAGYVAGDGAMRAAGAGKWGMRRRDGTVAYAAS 
                         :           *     ..      .       .                 
 
MorA    GWLTDAGGDGET  358 
MmoS2   AAMQEALQAGQP  279 
FixL    GYLKRYH-----  79 
RbdA    EGMLLIEQ----  311 
NtrB    DNRRGAVGVVS- 
                             
Fig. 6-14.  Sequence alignment of the first MorA PAS domain.  The PAS mutation 
obtained through our PCR-error based screen was at a weakly conserved site. Therefore, 
further studies at conserved residues such as G312, N318, and P319 may allow a better 
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7.   Conclusion  and future work  
7.1. Conclusions 
In this work, the role of c-di-GMP signalling in controlling motility and biofilm 
formation has been described. This is based on a sensor-regulator, MorA, from two 
species of Pseudomonas.  
Firstly, the swimming patterns of monotrichous and multitrichous flagellated 
Pseudomonas spp. were compared. Key movements of the monotrichous flagellar 
motor were described for the first time these are similar to the “run” and “reverse” 
swimming pattern. A working model for the swimming motility of monotrichous 
bacteria was thus developed. Unlike peritrichous E. coli, the flagellar motor of P. 
aeruginosa exhibits significant CW rotations. Other functions of the P. aeruginosa 
flagellar motor include CCW rotations, pausing, and switching. 
In contrast to P. putida, where motility is regulated at the level of transcription, we 
show that MorA-Pa affects the flagellar motor function of P. aeruginosa through post-
transcriptional control. The DGC function of MorA-Pa affects both CCW and the 
pause stages of the motor function.  How c-di-GMP levels affect motor function are 
not clear yet, although it is noteworthy that both the flagellar apparatus and MorA-Pa 
are polar-localized (Fu and Swarup, Unpublished), which raises the possibility that 
there may be interactions between the two.                                                                                                          
The inter-domain effects of PDE domain on DGC function includes both stimulatory 
and inhibitory effects. While the first effect is substrate-independent, the latter is c-di-
GMP concentration-dependent. Coexistence of the two domains has a very close 
relationship which involves the recruitment of PDE residues for the regulation of 
 141 
 
DGC activity.  A longstanding conundrum of the role of joint occurrence of domains 
that can encoded opposing enzymatic functions of DGC and PDE activities have been 
directly addressed here.   
MorA-mediated DGC activity affects motility and biofilm formation.  While the PDE 
domain plays a role in DGC function, its own activity becomes important selectively 
at a later stage of biofilm development. The major DGC activity is not only regulated 
by PDE but is also affected by the sensory domain. P. aeruginosa studies likely did 
not include the same stage of biofilm development as P. putida, where PDE activation 
was observed. Therefore, in future, the effect of the sensory domain on PDE function 
can be studied.  
7.2. MorA accumulates c-di-GMP in a linear fashion across a broad range of 
c-di-GMP levels for different biological outcomes 
To conclude the findings of this report, we propose a model for the regulation of c-di-
GMP levels by MorA activity and its outcomes on motility, and biofilm formation 
(Fig. 7-1). At low c-di-GMP levels, cells are very motile and less biofilm is formed 
(Fig. 7-1. top panel). When DGC activity leads to moderate c-di-GMP levels, motility 
reduces and more biofilm initiation and formation at a later stage of biofilm 
development, take place. At moderate c-di-GMP levels, the PDE domain reduces the 
rate of c-di-GMP accumulation via product inhibition (Fig. 7-1, middle panel). At high 
c-di-GMP levels, product inhibition increases, and, together with activation of PDE 
activity during the later stage of biofilm development stage, lead to reduction of c-di-
GMP levels to either moderate or low levels (Fig. 7-1, bottom panel). Across all these 
stages, the PAS domain acts to regulate the catalytic activity of MorA by sensing an 
environmental signal. It is also likely that the effect of PAS regulation is less 
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significant during the later stage of biofilm development. As with most signal 
transduction systems, the small changes in levels of c-di-GMP levels led to large 
effects on biological function. This model, therefore, explains how functioning of the 
sensory and catalytic domains, working in a finely-tuned manner helps restrict c-di-
GMP levels to a narrow working range in order to differentially control motility and 
biofilm formation in a pathway- and developmental stage- specific manner.   
One of the major conclusions of this study is the exquisite mechanism of the control of 
intracellular c-di-GMP levels via inter-domain interactions of DGC and PDE activity, 
and how this affects biological function. Catalytic mechanisms that fine-tune c-di-
GMP levels can lead to different biological outcomes, such as the transcriptional and 
post-transcriptional control of motility for P. putida and P. aeruginosa, respectively. 
In addition, while cellular pathways have been shown to be regulated by c-di-GMP 
effectors, here, we show that the control begins at the level of enzyme action, through 





Fig. 7-1. MorA accumulates c-di-GMP in a linear fashion across a broad range of 
c-di-GMP levels for different biological outcomes. MorA DGC activity is 
dependent on a functional PDE domain. At low c-di-GMP levels, cells are very motile 
and low levels of biofilm are formed (top panel).  MorA DGC activity leads to 
accumulation of c-di-GMP to moderate levels. At moderate levels, motility is reduced 
and moderate levels of biofilm are formed at initiation and a later stage of biofilm 
development (middle panel). The PDE domain senses c-di-GMP and causes product 
inhibition, slowing down c-di-GMP accumulation (middle panel). As c-di-GMP 
accumulate to high levels, cells are not motile and high levels of biofilm are formed at 
initiation and a later stage of biofilm development (bottom panel). Strong product 
inhibition take place and interaction of c-di-GMP at the PDE domain also results in 
PDE activity. These two mechanisms act to regulate c-di-GMP back to moderate or 
low levels (bottom panel). These catalytic mechanisms are also regulated by the PAS 





7.3. Future work 
From this study, we thus propose the following future work: 
 To test other nucleotides as a substrate for MorA catalytic activity 
 To test other GTP and c-di-GMP analogues that bind to GGDEF or EAL 
domains of MorA  
 To study the binding of the inhibitory c-di-GMP to rMorA and its PDE point 
mutants 
 To establish if PDE activation plays a role at the later stage of biofilm 
development in P. aeruginosa  
 To establish the duration of PDE activation, and if it affects biofilm dispersal 
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Appendix  I 
 
Sequence verification for site-directed mutant clones 
 
A -  Sequence alignments for protein expression clones 
 
Clone: pET rMorA (Full –length sequence verification)
Sbjct: MorA cds, Genbank: gb|AY323811.1| 
 
BLAST Result:  
Score = 2483 bits (1344),  Expect = 0.0 





















Clone: pET E929K (Full–length sequence verified, mutated site shown) 
Sbjct: MorA cds, Genbank: gb|AY323811.1| 
 
Score = 2477 bits (1341),  Expect = 0.0 
Identities = 1343/1344 (99%), Gaps = 0/1344 (0%) 
Strand=Plus/Minus 
 
pET E929K  1021  CGCCAGTTCGCGATTGGAGCGATGCTGCAGCAGCAAGGTGAATTTGTCGCCGCCCATGCG  1080 
                 |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||| 
Sbjct      4049  CGCCAGTTCGCGATTGGAGCGATGCTGCAGCAGCAAGGTGAATTCGTCGCCGCCCATGCG  3990 
 
Translated seq   RMGGDKFTLLLQHRSNRELA 
 
Clone: pET E1058K (Full–length sequence verified, mutated site shown) 
Sbjct: MorA cds, Genbank: gb|AY323811.1| 
 
Score = 2477 bits (1341),  Expect = 0.0 
Identities = 1343/1344 (99%), Gaps = 0/1344 (0%) 
Strand=Plus/Plus 
 
pET E1058K  661  GGCGCCAAAGCGCTGCTGCGCTGGCGACATCCGCGTCGCGGGCTGGTGCCGCCGGGTGAT  720 
                 |||||| ||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  4386      GGCGCCGAAGCGCTGCTGCGCTGGCGACATCCGCGTCGCGGGCTGGTGCCGCCGGGTGAT  4445 
 
Translated seq   GAKALLRWRHPRRGLVPPGD 
 
Clone: pET L1060G (Full–length sequence verified, mutated site shown) 
Sbjct: MorA cds, Genbank: gb|AY323811.1| 
 
Score = 2466 bits (1335),  Expect = 0.0 
Identities = 1342/1345 (99%), Gaps = 2/1345 (0%) 
Strand=Plus/Plus 
  
pET L1060G  661   GGCGCCGAAGCGG-GCCTGCGCTGGCGACATCCGCGTCGCGGGCTGGTGCCGCCGGGTGA  719 
                   ||||||||||||  || ||||||||||||||||||||||||||||||||||||||||||| 
Sbjct       4386  GGCGCCGAAGCGCTGC-TGCGCTGGCGACATCCGCGTCGCGGGCTGGTGCCGCCGGGTGA  4444 
 





Clone: pET rMorA-Pa (Full–length sequence verified)
Sbjct: MorA-Pa cds, GenBank: AAG07989.1 
BLAST Result:  
Score = 2444 bits (1323),  Expect = 0.0 






















B -  Sequence alignments for P. putida pMorA (pGB1MorA) plasmids 
 
Clone: pE929K(Full–length sequence verified, mutated site shown)
Sbjct: MorA cds, Genbank: gb|AY323811.1|  
 
Score = 1.125e+04 bits (6093),  Expect = 0.0 
Identities = 6095/6096 (99%), Gaps = 0/6096 (0%) 
Strand=Plus/Plus 
 
pE929K    3961  CCTGCGTCGATGACGACGACACCGTGGCGCGCATGGGCGGCGACAAATTCACCTTGCTGC  4020 
                |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||| 
Sbjct     3961  CCTGCGTCGATGACGACGACACCGTGGCGCGCATGGGCGGCGACGAATTCACCTTGCTGC  4020 
 
Translated seq  CVDDDDTVARMGGDKFTLL 
 
Clone: pE1058K(Full–length sequence verified, mutated site shown) 
Sbjct: MorA cds, Genbank: gb|AY323811.1| 
 
Score = 1.125e+04 bits (6093),  Expect = 0.0 
Identities = 6095/6096 (99%), Gaps = 0/6096 (0%) 
Strand=Plus/Plus 
 
pE1058K     4381  TGACCGGCGCCAAAGCGCTGCTGCGCTGGCGACATCCGCGTCGCGGGCTGGTGCCGCCGG  4440 
                  ||||||||||| |||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct       4381  TGACCGGCGCCGAAGCGCTGCTGCGCTGGCGACATCCGCGTCGCGGGCTGGTGCCGCCGG  4440 
 
Translated seq    TGAKALLRWRHPRRGLVPP 
 
Clone: pL1060G (Full–length sequence verified, mutated site shown) 
Sbjct: MorA cds, Genbank: gb|AY323811.1| 
 
Score = 1.124e+04 bits (6087),  Expect = 0.0 
Identities = 6094/6097 (99%), Gaps = 2/6097 (0%) 
Strand=Plus/Plus 
 
pL1060G    4381  TGACCGGCGCCGAAGCGG-GCCTGCGCTGGCGACATCCGCGTCGCGGGCTGGTGCCGCCG  4439 
                 |||||||||||||||||  || |||||||||||||||||||||||||||||||||||||| 
Sbjct      4381  TGACCGGCGCCGAAGCGCTGC-TGCGCTGGCGACATCCGCGTCGCGGGCTGGTGCCGCCG  4439 
 




C -  Sequence alignments for P. aeruginosa pUPMR plasmids 
 
Clone: pUPMR P* (Full–length sequence verified, mutated site shown) 
Sbjct: MorA-Pa cds, GenBank: AAG07989.1 
 
Score = 7840 bits (4245),  Expect = 0.0 
Identities = 4247/4248 (99%), Gaps = 0/4248 (0%) 
Strand=Plus/Plus 
 
pUPMR P*  1021  CTGCCGGACCTCGAGCCAGGCTGGCTGACGGACGTCGGTGGCGACGGCGAGACCCGTAGC  1080 
                 |||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||| 
Sbjct      1021  CTGCCGGACCTCGAGCCAGGCTGGCTGACGGACGCCGGTGGCGACGGCGAGACCCGTAGC  1080 
 
Translated seq   LPDLEPGWLTDVGGDGETRS 
 
Clone: pUPMR G* (Full–length sequence verified, mutated site shown) 
Sbjct: MorA-Pa cds, GenBank: AAG07989.1 
 
Score = 7840 bits (4245),  Expect = 0.0 
Identities = 4247/4248 (99%), Gaps = 0/4248 (0%) 
Strand=Plus/Plus 
 
pUPMR G*  3121  ACCCGCCTGAGCGCCTGCGTCAGCCAGGACGATACCGTGGCGCGCATGGGCGGCGACAAA  3180 
                 ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct      3121  ACCCGCCTGAGCGCCTGCGTCAGCCAGGACGATACCGTGGCGCGCATGGGCGGCGACGAA  3180 
 
pUPMR G*  3181  TTCACCCTGCTGCTGCCTTCCCAGGGCGACCGCGAGATCGCCCTGAAACGGGCGATCCAG  3240 
                 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct      3181  TTCACCCTGCTGCTGCCTTCCCAGGGCGACCGCGAGATCGCCCTGAAACGGGCGATCCAG  3240 
 
Translated seq   TRLSACVSQDDTVARMGGDKFFTLLLPSQGDREIALKRAIQ 
 
Clone: pUPMR K* (Full–length sequence verified, mutated site shown) 
Sbjct: MorA-Pa cds, GenBank: AAG07989.1 
 
Score = 7834 bits (4242),  Expect = 0.0 
Identities = 4246/4248 (99%), Gaps = 0/4248 (0%) 
Strand=Plus/Plus 
  
pUPMR K*  3541  GACGGCCGCCGCCTGACCGGTGCCAAGGCCCTGCTGCGCTGGCAGCATCCGCGCCGCGGA  3600 
                 |||||||||||||||||||| ||| ||||||||||||||||||||||||||||||||||| 
Sbjct      3541  GACGGCCGCCGCCTGACCGGCGCCGAGGCCCTGCTGCGCTGGCAGCATCCGCGCCGCGGA  3600 
 
Translated seq   DGRRLTGAKALLRWQHPRRG 
 
Clone: pUPMR P* G* (Full–length sequence verified, mutated site shown) 
Sbjct: MorA-Pa cds, GenBank: AAG07989.1 
 
Score = 7834 bits (4242),  Expect = 0.0 
Identities = 4246/4248 (99%), Gaps = 0/4248 (0%) 
Strand=Plus/Plus 
 
pUPMR P* G* 1021  CTGCCGGACCTCGAGCCAGGCTGGCTGACGGACGTCGGTGGCGACGGCGAGACCCGTAGC  1080 
                    |||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||| 
Sbjct         1021  CTGCCGGACCTCGAGCCAGGCTGGCTGACGGACGCCGGTGGCGACGGCGAGACCCGTAGC  1080 
 
pUPMR P* G*  3121  ACCCGCCTGAGCGCCTGCGTCAGCCAGGACGATACCGTGGCGCGCATGGGCGGCGACAAA  3180 
                    ||||||||||||||||||||||||||||||||||||||||||||||||||||||||| || 
Sbjct         3121  ACCCGCCTGAGCGCCTGCGTCAGCCAGGACGATACCGTGGCGCGCATGGGCGGCGACGAA  3180 
 
pUPMR P* G*  3181  TTCACCCTGCTGCTGCCTTCCCAGGGCGACCGCGAGATCGCCCTGAAACGGGCGATCCAG  3240 
                    |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct         3181  TTCACCCTGCTGCTGCCTTCCCAGGGCGACCGCGAGATCGCCCTGAAACGGGCGATCCAG  3240 
 
Translated seq   LPDLEPGWLTDVGGDGETRS 





Clone: pUPMR P* K* (Full–length sequence verified, mutated site shown) 
Sbjct: MorA-Pa cds, GenBank: AAG07989.1 
 
Score = 7829 bits (4239),  Expect = 0.0 
Identities = 4245/4248 (99%), Gaps = 0/4248 (0%) 
Strand=Plus/Plus 
pUPMR P* K*  1021  CTGCCGGACCTCGAGCCAGGCTGGCTGACGGACGTCGGTGGCGACGGCGAGACCCGTAGC  1080 
                    |||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||| 
Sbjct         1021  CTGCCGGACCTCGAGCCAGGCTGGCTGACGGACGCCGGTGGCGACGGCGAGACCCGTAGC  1080 
 
pUPMR P* K*  3541  GACGGCCGCCGCCTGACCGGTGCCAAGGCCCTGCTGCGCTGGCAGCATCCGCGCCGCGGA  3600 
                    |||||||||||||||||||| ||| ||||||||||||||||||||||||||||||||||| 
Sbjct         3541  GACGGCCGCCGCCTGACCGGCGCCGAGGCCCTGCTGCGCTGGCAGCATCCGCGCCGCGGA  3600 
 
Translated seq   LPDLEPGWLTDVGGDGETRS 




Appendix  II 
Sequence alignment of rMorA and rMorA-Pa 
82% Similar 
 
Score =  754 bits (1947),  Expect = 0.0, Method: Compositional matrix adjust. 
Identities = 362/441 (82%), Positives = 397/441 (90%), Gaps = 0/441 (0%) 
 
rMorA-Pa  1    RKASERRIHRLAYYDALTHLPNRTLFQDRLHTALQQAERNGQWVVLMFLDLDRFKPINDS  60 
               RKASE+RIHRLAYYDALTHLPNRTLFQDRLHTALQ AER   WVVLMFLDLD FKPINDS 
rMorA     1    RKASEQRIHRLAYYDALTHLPNRTLFQDRLHTALQAAERQKSWVVLMFLDLDHFKPINDS  60 
 
rMorA-Pa  61   LGHAAGDRMLQEVATRLSACVSQDDTVARMGGDEFTLLLPSQGDREIALKRAIQVAELIL  120 
               LGHAAGDRML+++ATRL ACV  DDTVARMGGDEFTLLL  + +RE+A  RAI VAE IL 
rMorA     61   LGHAAGDRMLKDMATRLLACVDDDDTVARMGGDEFTLLLQHRSNRELACNRAIHVAEQIL  120 
 
rMorA-Pa  121  GRLARPFTLEGREFFVTASIGVALSPQDGAELSLLMKNADTAMYHAKEMGKNNFQFYQAE  180 
                 L RPF LEGREFFVTASIG+ALSPQDG ELS LMKNADTAMYHAKE GKNNFQFYQA+ 
rMorA     121  ASLVRPFVLEGREFFVTASIGIALSPQDGNELSQLMKNADTAMYHAKERGKNNFQFYQAD  180 
 
rMorA-Pa  181  MNARALERLELESDLRRALELGEFVLHYQPQFTGDGRRLTGAEALLRWQHPRRGLVPPSE  240 
               MNA ALERLELESDLR ALE  EFVL+YQPQF+GDG+RLTGAEALLRW+HPRRGLVPP + 
rMorA     181  MNASALERLELESDLRHALEQNEFVLYYQPQFSGDGKRLTGAEALLRWRHPRRGLVPPGD  240 
 
rMorA-Pa  241  FIPVLEEIGLVAQVGDWLLAEACKQLRSWHKAKVRVPKVSVNLSARQFADGQLGERIAAI  300 
               FIPVLEE+GLV  VGDW+++EAC+QL++WH+ +VRVPKVSVN+SARQF+DGQLG RIA I 
rMorA     241  FIPVLEELGLVVDVGDWVISEACRQLKTWHQQRVRVPKVSVNISARQFSDGQLGTRIATI  300 
 
rMorA-Pa  301  LYETGIPPACLELELTESILMSDVAEAMQILSGLKRLGLAIAVDDFGTGYSSLNYLKQFP  360 
               L ETG+PPACLELELTESILM +V+EAMQIL+GLK LGL+IAVDDFGTGYSSLNYLKQFP 
rMorA     301  LRETGLPPACLELELTESILMREVSEAMQILAGLKNLGLSIAVDDFGTGYSSLNYLKQFP  360 
 
rMorA-Pa  361  IDVLKIDRSFVDGLPHGEQDAQIARAIIAMAHSLNLMVIAEGVESQAQLDFLREHGCDEV  420 
               IDVLKIDR+FVDGLP GEQDAQIARAIIAMAHSLNL VIAEGVE+  QLDFLREHGCDEV 
rMorA     361  IDVLKIDRTFVDGLPSGEQDAQIARAIIAMAHSLNLAVIAEGVETHEQLDFLREHGCDEV  420 
 
rMorA-Pa  421  QGYLFGRPMPAEQFGMLYASD  441 
               QGYLFGRPMPA +F   + +D 
rMorA     421  QGYLFGRPMPAGRFEAQFCND  441 






In silico model of rMorA DXXD site 
 
In silico model of GGDEFMorA superimposed with PleD. The GGDEFMorA domain 
likely does not possess the RXXD allosteric c-di-GMP binding I-site. The 
GGDEFMorA surface structure corresponding to the PleD RXXD I-site is represented 
in the cartoon. While c-di-GMP binds to the I-site of PleD, here, we observe a clash 
of c-di-GMP with MorA. This verifies our sequence analyses data that MorA, without 







Appendix  IV 
Sequence similarity of MorA to PleD and tdEAL, used for in silico modelling of 
domain structures 




Score = 89.0 bits (219),  Expect = 1e-22, Method: Compositional matrix adjust. 
Identities = 59/165 (35%), Positives = 88/165 (53%), Gaps = 8/165 (4%) 
 
rMorA  11   LAYYDALTHLPNRTLFQDRLHTALQAAERQKSWVVLMFLDLDHFKPINDSLGHAAGDRML  70 
            LA  D LT L NR     +L + ++ A      V  + +D+D FK IND+ GH  GD +L 
PleD   287  LAVTDQLTGLHNRRYMTGQLDSLVKRATLGGDPVSALLIDIDFFKKINDTFGHDIGDEVL  346 
 
rMorA  71   KDMATRLLACVDDDDTVARMGGDEFTLLLQHRSNRELACNRAIHVAEQILASLV-RPF-V  128 
            ++ A RL + V   D   R GG+EF +++      + A   A+ +AE+I   +   PF V 
PleD   347  REFALRLASNVRAIDLPCRYGGEEFVVIMP-----DTALADALRIAERIRMHVSGSPFTV  401 
 
rMorA  129  LEGREFF-VTASIGIALSPQDGNELSQLMKNADTAMYHAKERGKN  172 
              GRE   VT SIG++ +  +G+    L+K AD  +Y AK  G+N 
PleD   402  AHGREMLNVTISIGVSATAGEGDTPEALLKRADEGVYQAKASGRN  446 
 




Score =  222 bits (566),  Expect = 5e-63, Method: Compositional matrix adjust. 
Identities = 114/247 (46%), Positives = 151/247 (61%), Gaps = 2/247 (1%) 
 
Query  1    ERLELESDLRHALEQNEFVLYYQPQFSGDGKRLTGAEALLRWRHPRRGLVPPGDFIPVLE  60 
            ERL L++ LR ALE+NE VL+YQP       R+ G EAL+RW  P RGLV P  FIP  E 
Sbjct  1    ERLTLDTRLRQALERNELVLHYQPIVELASGRIVGGEALVRWEDPERGLVMPSAFIPAAE  60 
 
Query  61   ELGLVVDVGDWVISEACRQLKTWHQQRVRVP--KVSVNISARQFSDGQLGTRIATILRET  118 
            + GL+V + DWV+   C QL+ W QQ        +SVNIS RQF    L   +   L  + 
Sbjct  61   DTGLIVALSDWVLEACCTQLRAWQQQGRAADDLTLSVNISTRQFEGEHLTRAVDRALARS  120 
 
Query  119  GLPPACLELELTESILMREVSEAMQILAGLKNLGLSIAVDDFGTGYSSLNYLKQFPIDVL  178 
            GL P CLELE+TE++++    E    L  L+  G+ +A+DDFGTGYSSL+YL Q P   L 
Sbjct  121  GLRPDCLELEITENVMLVMTDEVRTCLDALRARGVRLALDDFGTGYSSLSYLSQLPFHGL  180 
 
Query  179  KIDRTFVDGLPSGEQDAQIARAIIAMAHSLNLAVIAEGVETHEQLDFLREHGCDEVQGYL  238 
            KID++FV  +P+   + QI   I+A+A  L + V+AEG+ET +Q  FLR+ GC+  QG L 
Sbjct  181  KIDQSFVRKIPAHPSETQIVTTILALARGLGMEVVAEGIETAQQYAFLRDRGCEFGQGNL  240 
 
Query  239  FGRPMPA  245 
               P  A 






Appendix  V 
List of videos illustrating different cell motions (attached CD) 
 
Cell motion Strain Filename 
   
Tethered-cell motion   
CCW WT-Pa CCW_WT.avi 
CW WT-Pa CW_WT.avi 
Switch WT-Pa SWI_WT.avi 
Pause WT-Pa PAU_WT.avi 
   
Typical rotating tethered cell WT-Pa WT_Pa_tethered.avi 
Typical rotating tethered cell ΔmorA-Pa MorA_Pa_tethered.avi 
Typical rotating tethered cell ΔmorA-Pa pUPMR GGDKF_Pa_tethered.avi 
   
Free-swimming cells   
P. putida WT WT WT_Pp.avi 
P. putida ΔmorA ΔmorA MorA_Pp.avi 
P. aeruginosa WT-Pa WT-Pa WT_Pa.avi 
P. aeruginosa ΔmorA-Pa ΔmorA-Pa MorA_Pa.avi 
 
 
 
